<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>PEARL (Pharmacy Enforcement Acts & Regulation Lexicon)</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;700&display=swap" rel="stylesheet">
    <style>
        :root {
            --primary-color-light: #0056b3;
            --secondary-color-light: #007bff;
            --background-color-light: #f8f9fa;
            --content-bg-color-light: #ffffff;
            --text-color-light: #212529;
            --border-color-light: #dee2e6;
            --sidebar-bg-light: #e9ecef;
            --highlight-bg-light: #ffc107;
            --highlight-text-light: #343a40;
            --button-bg-light: var(--primary-color-light);
            --button-text-light: #ffffff;

            --primary-color-dark: #4dabf7; /* Lighter blue for dark mode */
            --secondary-color-dark: #74c0fc;
            --background-color-dark: #121212;
            --content-bg-color-dark: #1e1e1e;
            --text-color-dark: #e0e0e0;
            --border-color-dark: #444444;
            --sidebar-bg-dark: #2c2c2c;
            --highlight-bg-dark: #fcc419;
            --highlight-text-dark: #121212;
            --button-bg-dark: var(--primary-color-dark);
            --button-text-dark: #121212;

            /* Default to light theme variables */
            --primary-color: var(--primary-color-light);
            --secondary-color: var(--secondary-color-light);
            --background-color: var(--background-color-light);
            --content-bg-color: var(--content-bg-color-light);
            --text-color: var(--text-color-light);
            --border-color: var(--border-color-light);
            --sidebar-bg: var(--sidebar-bg-light);
            --highlight-bg: var(--highlight-bg-light);
            --highlight-text: var(--highlight-text-light);
            --button-bg: var(--button-bg-light);
            --button-text: var(--button-text-light);

            --sidebar-width: 280px;
            --base-font-size: 16px; /* For font scaling */
        }

        body {
            font-family: 'Inter', Arial, sans-serif;
            line-height: 1.7;
            margin: 0;
            padding-left: var(--sidebar-width);
            background-color: var(--background-color);
            color: var(--text-color);
            transition: padding-left 0.3s ease, background-color 0.3s ease, color 0.3s ease;
            font-size: var(--base-font-size);
        }
        body.dark-theme {
            --primary-color: var(--primary-color-dark);
            --secondary-color: var(--secondary-color-dark);
            --background-color: var(--background-color-dark);
            --content-bg-color: var(--content-bg-color-dark);
            --text-color: var(--text-color-dark);
            --border-color: var(--border-color-dark);
            --sidebar-bg: var(--sidebar-bg-dark);
            --highlight-bg: var(--highlight-bg-dark);
            --highlight-text: var(--highlight-text-dark);
            --button-bg: var(--button-bg-dark);
            --button-text: var(--button-text-dark);
        }
        body.toc-collapsed { padding-left: 0; }

        .container {
            max-width: 900px; margin: 20px auto; padding: 25px;
            background-color: var(--content-bg-color);
            box-shadow: 0 0 15px rgba(0,0,0,0.1);
            border-radius: 8px;
            transition: background-color 0.3s ease;
        }

        #toc-sidebar {
            background-color: var(--sidebar-bg); border-right: 1px solid var(--border-color);
            position: fixed; top: 0; left: 0; width: var(--sidebar-width); height: 100vh;
            overflow-y: auto; padding: 20px 10px; box-sizing: border-box;
            z-index: 1100; transition: transform 0.3s ease, background-color 0.3s ease;
            transform: translateX(0);
        }
        #toc-sidebar.collapsed { transform: translateX(calc(-1 * var(--sidebar-width))); }
        #toc-sidebar h4 { color: var(--primary-color); text-align: center; margin-top: 0; border-bottom: 1px solid var(--border-color); padding-bottom: 10px; }
        #toc-sidebar ul { list-style: none; padding: 0; margin: 0; }
        #toc-sidebar li a { display: block; padding: 8px 15px; color: var(--text-color); text-decoration: none; border-radius: 4px; font-size: 0.9em; transition: background-color 0.2s ease, color 0.2s ease; }
        #toc-sidebar li a.active-toc-link,
        #toc-sidebar li a:hover { background-color: var(--primary-color); color: var(--button-text); /* Use button-text for better contrast on dark theme */ }

        #toc-sidebar li a.toc-act-title {
            font-weight: bold; font-size: 0.95em; color: var(--primary-color);
            margin-top: 10px; background-color: rgba(0,0,0,0.05);
            display: flex; align-items: center; cursor: pointer;
        }
        .toc-act-toggle-icon { margin-right: 8px; transition: transform 0.2s ease-in-out; display: inline-block; }
        .toc-act-toggle-icon.collapsed { transform: rotate(-90deg); }

        body.dark-theme #toc-sidebar li a.toc-act-title { background-color: rgba(255,255,255,0.05); }
        #toc-sidebar li a.toc-act-title:hover { background-color: var(--secondary-color); }
        #toc-sidebar ul.toc-sections {
            padding-left: 10px;
            max-height: 1000px; /* Adjust if needed for very long lists of sections */
            overflow: hidden;
            transition: max-height 0.3s ease-in-out;
        }
        #toc-sidebar ul.toc-sections.collapsed { max-height: 0; }
        #toc-sidebar ul.toc-sections li a { padding-left: 25px; font-size: 0.85em; }


        #toc-toggle-button {
            background-color: var(--button-bg); color: var(--button-text);
            position: fixed; top: 15px; left: var(--sidebar-width); z-index: 1200; border: none; padding: 10px 12px; cursor: pointer; border-radius: 0 5px 5px 0; font-size: 1.2em; transition: left 0.3s ease, transform 0.3s ease, background-color 0.3s ease; box-shadow: 2px 0 5px rgba(0,0,0,0.1);
        }
        body.toc-collapsed #toc-toggle-button { left: 0; }

        #top-controls-wrapper {
            position: sticky; top: 0; z-index: 1000;
            background-color: var(--content-bg-color);
            padding: 10px 15px;
            border-bottom: 2px solid var(--border-color);
            box-shadow: 0 2px 5px rgba(0,0,0,0.05);
            margin-bottom: 20px;
            transition: background-color 0.3s ease, border-color 0.3s ease;
        }
        #accessibility-controls { display: flex; justify-content: center; align-items: center; gap: 10px; margin-bottom: 10px; font-size: 0.9em; }
        #accessibility-controls button, #accessibility-controls select { padding: 5px 8px; font-size: 0.85em; border-radius: 4px; background-color: var(--button-bg); color: var(--button-text); border: 1px solid var(--border-color); cursor: pointer; transition: background-color 0.3s ease, color 0.3s ease, border-color 0.3s ease; }
        #accessibility-controls button:hover, #accessibility-controls select:hover { opacity: 0.8; }
        #search-area { display: flex; flex-direction: column; align-items: center; gap: 10px; }
        #search-input-group { display: flex; align-items: center; gap: 8px; width: 100%; justify-content: center; flex-wrap: wrap; }
        #search-box { padding: 10px; width: 60%; max-width: 350px; border: 1px solid var(--border-color); border-radius: 6px; font-size: 0.95em; background-color: var(--content-bg-color); color: var(--text-color); }
        #search-act-filter { padding: 10px; border: 1px solid var(--border-color); border-radius: 6px; font-size: 0.90em; background-color: var(--content-bg-color); color: var(--text-color); }

        .search-controls { display: flex; flex-wrap: wrap; justify-content: center; gap: 8px; width: 100%; }
        .search-controls button { padding: 6px 10px; background-color: var(--button-bg); color: var(--button-text); border: none; border-radius: 6px; cursor: pointer; font-size: 0.85em; transition: background-color 0.3s ease; }
        .search-controls button:hover { opacity:0.8; }
        .search-controls button:disabled { background-color: #aaa; color: #eee; cursor: not-allowed; opacity: 0.7; }
        body.dark-theme .search-controls button:disabled { background-color: #555; color: #999;}
        #search-status { font-size: 0.9em; color: var(--text-color); min-width: 80px; text-align: center; margin-top: 4px; }

        /* Logo Styling - NEW */
        .header-logo-container {
            text-align: center; /* Center the logo container */
            padding: 20px 0; /* Add some padding around the logo */
            border-bottom: 3px solid var(--primary-color); /* Keep a similar border to old H1 */
            margin-bottom: 30px;
        }
        .header-logo {
            max-width: 350px; /* Adjust as needed for desired desktop size */
            height: auto; /* Maintain aspect ratio */
            display: inline-block; /* Allows centering via text-align on parent */
        }
        @media (max-width: 600px) {
            .header-logo {
                max-width: 80%; /* Logo takes more width on smaller screens */
            }
        }
        /* End Logo Styling */


        /* h1 was here, now replaced by logo container */

        .act-section { border: 1px solid var(--border-color); padding: 20px; margin-bottom: 40px; border-radius: 8px; background-color: var(--content-bg-color); transition: background-color 0.3s ease, border-color 0.3s ease;}
        .act-section .section ul, .act-section > ul {
            list-style-type: none;
            padding-left: 20px;
        }
        .act-section-header { display: flex; justify-content: space-between; align-items: center; margin-bottom: 15px; flex-wrap: wrap; gap: 10px;}
        .act-section > h2 { font-size: 1.8em; color: var(--primary-color); text-align: center; border-bottom: 2px solid var(--primary-color); margin-top: 0; padding-bottom: 10px; margin-bottom: 25px; scroll-margin-top: 150px; flex-grow: 1; }
        .toggle-sections-btn { padding: 5px 10px; font-size: 0.8em; background-color: var(--secondary-color); color: var(--button-text); border: none; border-radius: 4px; cursor: pointer; transition: background-color 0.3s ease; }
        .toggle-sections-btn:hover { opacity: 0.8; }

        .act-section h3 { color: var(--secondary-color); border-bottom-style: dashed; font-size: 1.4em; scroll-margin-top: 150px; }
        .act-section .section { position: relative; margin-bottom: 30px; padding-bottom: 25px; border-bottom: 1px dashed var(--border-color); transition: max-height 0.5s ease-out, opacity 0.3s ease-out, visibility 0.3s, margin-bottom 0.3s, padding-bottom 0.3s; max-height: 5000px; /* Increased for potentially long sections */ opacity: 1; visibility: visible; overflow: hidden;}
        .act-section .section.collapsed-section { max-height: 0; opacity: 0; visibility: hidden; margin-bottom: 0; padding-bottom: 0; border-bottom: none;}

        .copy-button { position: absolute; top: 0px; right: 0; background: #eee; border: 1px solid #ccc; border-radius: 4px; padding: 3px 8px; cursor: pointer; font-size: 0.8em; opacity: 0.3; transition: opacity 0.2s ease; }
        body.dark-theme .copy-button { background: #444; border-color: #555; color: #ccc; }
        .act-section .section:hover .copy-button { opacity: 1; }
        .copy-button:hover { background: #ddd; }
        body.dark-theme .copy-button:hover { background: #555; }

        .highlight { background-color: var(--highlight-bg); color: var(--highlight-text); font-weight: bold; padding: 2px 4px; border-radius: 3px; }
        .current-match { background-color: #ff8c00; box-shadow: 0 0 0 2px #ff8c00; }
        body.dark-theme .current-match { background-color: #ffa500; box-shadow: 0 0 0 2px #ffa500; }

        #scroll-to-top { background-color: var(--button-bg); color: var(--button-text); position: fixed; bottom: 20px; right: 20px; border: none; border-radius: 50%; width: 45px; height: 45px; font-size: 1.5em; cursor: pointer; display: none; box-shadow: 0 2px 10px rgba(0,0,0,0.2); z-index: 1050; transition: opacity 0.3s ease, visibility 0.3s ease, background-color 0.3s ease; opacity: 0; visibility: hidden; }
        #scroll-to-top.show { display: block; opacity: 0.8; visibility: visible; }
        #scroll-to-top:hover { opacity: 1; }

        table { width: 100%; border-collapse: collapse; margin: 25px 0; }
        th, td { border: 1px solid var(--border-color); padding: 12px; transition: border-color 0.3s ease;}
        th { background-color: var(--sidebar-bg); transition: background-color 0.3s ease;}
        li { margin-bottom: 8px; }
        .deleted { text-decoration: line-through; color: #6c757d; }
        body.dark-theme .deleted { color: #888; }
        :focus { outline: 2px solid var(--secondary-color); outline-offset: 2px; }

        @media print {
            body { padding-left: 0; background-color: white; color: black; }
            #toc-sidebar, #top-controls-wrapper, #scroll-to-top, #toc-toggle-button, .copy-button, .toggle-sections-btn, .header-logo-container /* Hide logo for print */ { display: none !important; }
            .container { max-width: 100%; margin: 0; padding: 0; box-shadow: none; border-radius: 0; }
            h2, h3 { color: black !important; border-bottom-color: black !important; } /* Changed h1 to h2 for act titles */
            a { text-decoration: none; color: black !important; }
            .highlight, .current-match { background-color: transparent !important; color: black !important; font-weight: normal; padding: 0; border-radius: 0; box-shadow: none; }
            .section, .act-section { border-bottom: 1px solid #ccc; border: none; padding: 0; margin-bottom: 20px;}
            .act-section .section.collapsed-section { max-height: none !important; opacity: 1 !important; visibility: visible !important; margin-bottom: 30px !important; padding-bottom: 25px !important; border-bottom: 1px dashed #ccc !important;}
        }
        @media (max-width: 900px) {
             body { padding-left: 0; }
             #toc-sidebar { transform: translateX(calc(-1 * var(--sidebar-width))); }
             #toc-sidebar.collapsed { transform: translateX(calc(-1 * var(--sidebar-width))); }
             body.toc-collapsed #toc-toggle-button,
             #toc-toggle-button { left: 0; }
             body.toc-open #toc-toggle-button { left: var(--sidebar-width); }
             body.toc-open #toc-sidebar { transform: translateX(0); }
             .container { padding: 15px; }
             .act-section > h2, .act-section h3 { scroll-margin-top: 120px; }
        }
        @media (max-width: 480px) {
            #search-input-group { flex-direction: column; }
            #search-box { width: 90%; max-width: none;}
            #search-act-filter { width: 90%; margin-top: 8px; }
             .act-section > h2, .act-section h3 { scroll-margin-top: 200px; /* Increased further for stacked controls */ }
            .header-logo-container h1 /* If you keep h1 for logo container */ { font-size: 1.8em; }
            .act-section > h2 { font-size: 1.5em; }
            .act-section h3 { font-size: 1.2em; }
        }
    </style>
</head>
<body>

    <button id="toc-toggle-button" aria-label="Toggle Table of Contents">&#9776;</button>
    <div id="toc-sidebar"><h4>Table of Contents</h4><ul id="toc-list"></ul></div>

    <div id="top-controls-wrapper">
        <div id="accessibility-controls">
            <span>Font:</span>
            <button id="font-decrease" aria-label="Decrease font size">-</button>
            <button id="font-increase" aria-label="Increase font size">+</button>
            <button id="theme-toggle" aria-label="Toggle theme">Toggle Theme</button>
        </div>
        <div id="search-area">
            <div id="search-input-group">
                <select id="search-act-filter" aria-label="Filter search by Act">
                    <option value="all">All Acts & Regulations</option>
                    </select>
                <input type="text" id="search-box" placeholder="Search..." aria-label="Search Term">
            </div>
            <div class="search-controls">
                 <button onclick="performSearch()" aria-label="Perform search">Search</button>
                 <button onclick="clearSearch()" aria-label="Clear search">Clear</button>
                 <button id="prev-match" onclick="goToPreviousMatch()" aria-label="Previous match" disabled>&lt; Prev</button>
                 <button id="next-match" onclick="goToNextMatch()" aria-label="Next match" disabled>Next &gt;</button>
                 <span id="search-status" aria-live="polite"></span>
            </div>
        </div>
    </div>

    <div class="container">
        <div class="header-logo-container">
            <img src="Pearl1.png" alt="PEARL (Pharmacy Enforcement Acts & Regulation Lexicon) Logo" class="header-logo">
        </div>

        <div id="content">
            <div id="soda" class="act-section">
                <div class="act-section-header">
                    <h2>SALE OF DRUGS ACT 1952 (REVISED - 1989)</h2>
                    <button class="toggle-sections-btn" aria-expanded="true" aria-controls="soda-sections-wrapper">Collapse Sections</button>
                </div>
                <div id="soda-sections-wrapper">
                    <div class="section" id="soda-arrangement">
                        <h3>ARRANGEMENT OF SECTIONS</h3>
                        <ul>
                            <li>Long Title</li>
                            <li>Section 1. Short title and application.</li>
                            <li>Section 2. Interpretation.</li>
                            <li>APPOINTMENT OF ANALYSTS, OFFICERS AND INSPECTORS AND THEIR POWERS AND DUTIES</li>
                            <li>Section 3. Appointment of analysts, officers and inspectors.</li>
                            <li>Section 4. Power of officers and inspectors to enter, etc.</li>
                            <li>Section 5. Power to demand, select, and take samples.</li>
                            <li>Section 6. Any person may have sample analysed.</li>
                            <li>Section 7. Samples how taken.</li>
                            <li>Section 8. Certificate of analyst.</li>
                            <li>Section 9. Power to call for information.</li>
                            <li>OFFENCES AND PENALTIES</li>
                            <li>Section 10. Offences and penalty.</li>
                            <li>Section 11. Interference with official marks.</li>
                            <li>Section 12. General penalty.</li>
                            <li>Section 13. Forfeiture of drugs upon conviction.</li>
                            <li>Section 14. Notification of conviction in newspapers.</li>
                            <li>PRESUMPTIONS OF LAW</li>
                            <li>Section 15. Adulteration.</li>
                            <li>Section 16. Sale by agent or servant.</li>
                            <li>Section 17. Presumptions as to sale for human consumption or use.</li>
                            <li>LEGAL PROCEEDINGS AND EVIDENCE</li>
                            <li>Section 18. Proceedings for offences.</li>
                            <li>Section 19. No defence that offence not wilfully committed.</li>
                            <li>Section 20. Reliance on written warranty a good defence.</li>
                            <li>Section 21. Analyst's certificate to be prima facie evidence.</li>
                            <li>Section 22. Court may order independent analysis.</li>
                            <li>Section 23. Non-disclosure.</li>
                            <li>Section 24. Recovery of fees and other expenses incidental to prosecution.</li>
                            <li>Section 25. Appeal.</li>
                            <li>REGULATIONS AND SUPPLEMENTAL PROVISIONS</li>
                            <li>Section 26. Power to make Regulations.</li>
                            <li>Section 27. Extended application of Act.</li>
                            <li>Section 28. Analysts' fees.</li>
                        </ul>
                    </div>
                    <div class="section" id="soda-long-title">
                        <h3>Long Title</h3>
                        <p>An Act relating to the sale of drugs.</p>
                        <p>[1 November 1952, L.N. 536/1952; Sabah and Sarawak-1 September 1999, P.U. (A) 380/1992; Federal Territory of Labuan-1 September 1989, P.U. (A) 381/1992]</p>
                    </div>
                    <div class="section" id="soda-sec1">
                        <h3>Section 1. Short title and application.</h3>
                        <p>(1) This Act may be cited as the Sale of Drugs Act 1952.</p>
                        <p>(2) This Act shall apply throughout Malaysia.</p>
                    </div>
                    <div class="section" id="soda-sec2">
                        <h3>Section 2. Interpretation.</h3>
                        <p>In this Act, unless the context otherwise requires-</p>
                        <p>"analyst" means an analyst appointed under this Act;</p>
                        <p>"appliance" includes the whole or any part of any utensil, machinery, instrument, apparatus, or article used, or intended for use, in or for the making, keeping, preparing, or supplying of any drug;</p>
                        <p>"drug" includes any substance, product or article intended to be used or capable, or purported or claimed to be capable, of being used on humans or any animal, whether internally or externally, for a medicinal purpose;</p>
                        <p>"importer" includes any person who, whether as owner, consignee, agent or broker, is in possession of, or in anywise entitled to the custody, or control, of the imported article;</p>
                        <p>"inspector" means any person appointed to be an inspector under section 3 of this Act;</p>
                        <p>"medicinal purpose" means any of the following purposes:</p>
                        <ul>
                            <li>(a) allevating, treating, curing or preventing a disease or a pathological condition or symptoms of a disease;</li>
                            <li>(b) diagnosing a disease or ascertaining the existence, degree or extent of a physiological or pathological condition;</li>
                            <li>(c) contraception;</li>
                            <li>(d) inducing anaesthesia;</li>
                            <li>(e) maintaining, modifying, preventing, restoring, or interfering with, the normal operation of a physiological function;</li>
                            <li>(f) controlling body weight;</li>
                            <li>(g) general maintainance or promotion of health or wellbeing;</li>
                        </ul>
                        <p>"Minister" means the Minister charged with responsibility for medical and health services;</p>
                        <p>"officer" means any Medical Officer of Health of the Medical Department of the Federal Government or of any State Government or of the Health Department of any Municipality, and includes the Director General of Chemistry, Malaysia, all Senior Chemists and Chemists of the Department of Chemistry and any person appointed to be an officer under section 3 of this Act;</p>
                        <p>"package" includes every means by which goods for carriage or for sale are cased, covered, enclosed, contained, or packed;</p>
                        <p>"sale" or "sell" includes barter and exchange and also includes offering or attempting to sell or causing or allowing to be sold or exposing for sale or receiving or sending or delivering for sale or having in possession for sale or having in possession any drug knowing that the same is likely to be sold or offered or exposed for sale.</p>
                    </div>
                    <div class="section" id="soda-sec3">
                        <h3>Section 3. Appointment of analysts, officers and inspectors.</h3>
                        <p>(1) The Yang di-Pertuan Agong may appoint such number of analysts as he may consider necessary for the purpose of this Act.</p>
                        <p>(2) The Chief Minister may appoint such number of officers and inspectors within a State as may be necessary for the purposes of this Act.</p>
                        <p>(3) The Minister may make regulations for the conduct of the duties of analysts, officers and inspectors under this Act.</p>
                        <p>(4) The analysts, officers and inspectors appointed under this section shall be deemed to be public servants within the meaning of the Penal Code [Act 574].</p>
                    </div>
                    <div class="section" id="soda-sec4">
                        <h3>Section 4. Power of officers and inspectors enter, etc.</h3>
                        <p>(1) Any officer or inspector may-</p>
                        <ul>
                            <li>(a) at all reasonable times enter into and inspect any place where he has reason to believe that there is any drug intended for sale;</li>
                            <li>(b) mark, seal, or otherwise secure, weigh, count or measure any drug, the sale, preparation, or manufacture of which is or appears to be contrary to this Act;</li>
                            <li>(c) inspect any drug, wherever found, which he has reasonable ground for believing to be intended for sale.</li>
                        </ul>
                        <p>(2) Any officer may-</p>
                        <ul>
                            <li>(a) seize any drug, wherever found, which is, or appears to be, unwholesome or deleterious to health;</li>
                            <li>(b) destroy any drug, wherever found, which is decayed or putrefied.</li>
                        </ul>
                        <p>(3) Any person claiming anything seized under this section may within forty-eight hours after such seizure complain thereof to the Court of a Magistrate and such complaint may be heard and determined by such court which may either confirm or disallow such seizure wholly or in part and may order the article seized to be restored.</p>
                        <p>(4) If within forty-eight hours after such seizure no complaint has been made or if such seizure is confirmed, the article seized shall become the property of the Government and shall be destroyed or otherwise disposed of so as to prevent its being used for human consumption.</p>
                        <p>(5) The period of forty-eight hours prescribed by subsections (3) and (4) may be enlarged by the Minister by regulation applicable to such districts or places as may be specified in the regulation.</p>
                        <p>(6) Where the seizure of any drug is made in any place which is not in the occupation of the owner of the thing seized, the officer making the seizure shall forthwith give notice in writing of the seizure to the owner or to the consignor or consignee or to the agent of the owner of the thing seized, if his name and address are attached thereto or are otherwise known to the officer and such address is within Malaysia.</p>
                    </div>
                    <div class="section" id="soda-sec5">
                        <h3>Section 5. Power to demand, select, and take samples.</h3>
                        <p>(1) On payment or tender to any person selling or making any drug, or to his agent or servant, of the current market value of the samples in this section referred to, any officer or inspector may at any place demand and select and take or obtain samples of the said drug for the purpose of analysis.</p>
                        <p>(2) Any such officer or inspector may require the said person or his agent or servant to show and permit the inspection of the package in which such drug is at the time kept and to take therefrom the samples demanded.</p>
                        <p>(3) Where any drug is kept for retail sale in an unopened package, no person shall be required by any officer or inspector to sell less than the whole of the contents of such package.</p>
                        <p>(4) Any person who refuses or neglects to comply with any demand or requisition made by an officer or inspector in pursuance of this section commits an offence.</p>
                    </div>
                    <div class="section" id="soda-sec6">
                        <h3>Section 6. Any person may have sample analysed.</h3>
                        <p>Any person, other than the seller, may, on payment of the prescribed fee together with the cost of the sample, require any officer or inspector to purchase a sample of any drug and submit the same for analysis.</p>
                    </div>
                    <div class="section" id="soda-sec7">
                        <h3>Section 7. Samples how taken.</h3>
                        <p>(1) Where it is intended to submit any sample for analysis, the officer or inspector purchasing or otherwise procuring it shall, before or forthwith after procuring it, inform the seller or his agent selling the article that he intends to have the same analyzed by an analyst.</p>
                        <p>(2) Such officer or inspector shall thereupon divide the sample into three parts and shall mark and seal or fasten up, in such manner as its nature will permit, each such part and shall offer one of such parts to the seller or his agent or the person having charge of the article.</p>
                        <p>(3) Such officer or inspector shall subsequently deliver, either personally or by registered letter, another of such parts to an analyst, and shall retain the third of such parts.</p>
                    </div>
                    <div class="section" id="soda-sec8">
                        <h3>Section 8. Certificate of analyst.</h3>
                        <p>(1) The certificate of the analyst shall be in the form prescribed.</p>
                        <p>(2) Where any method of analysis (chemical or physical) has been prescribed by regulations made under this Act for the analysis of any drug, any analyst either for the prosecution or defence shall follow, and shall in his certificate of analysis declare that he has followed, the prescribed method in his analysis.</p>
                        <p>(3) A copy of the result of any analysis of any drug procured by an officer or inspector may be obtained from the analyst by the person from whom the article so analyzed was purchased or obtained on payment of such fee as may be prescribed.</p>
                        <p>(4) No such copy of any analysis nor any reproduction thereof shall be displayed or used as an advertisement and if any person so displays or uses it he commits an offence against this Act.</p>
                    </div>
                    <div class="section" id="soda-sec9">
                        <h3>Section 9. Power to call for information.</h3>
                        <p>(1) If in the opinion of any officer appointed under section 3 there is reasonable ground for suspecting that any person is in possession of any drug or other substance for the purpose of sale or of manufacturing or preparing the same for sale in breach of this Act he may require such person to produce for his inspection any books or documents dealing with reception, possession, purchase, sale or delivery of any such drug or other substance.</p>
                        <p>(2) Any officer mentioned in subsection (1) may make or cause to be made copies of or extracts from any such books or documents, and such copies or extracts certified as such by such officer shall, unless the contrary is proved be deemed to be true and correct copies or extracts.</p>
                        <p>(3) Any person who refuses or neglects to comply with any requisition made in pursuance of this section commits an offence.</p>
                        <p>(4) Any officer who does not maintain the secrecy of all matters which come to his knowledge in the performance of his official duties under this section or who communicates any such matter to any person whomsoever except for the purpose of carrying into effect the provisions of this Act commits an offence and shall be liable on conviction to a fine of one thousand ringgit.</p>
                    </div>
                    <div class="section" id="soda-sec10">
                        <h3>Section 10. Offences and penalty.</h3>
                        <p>(1) Any person commits an offence who sells-</p>
                        <ul>
                            <li>(a) any adulterated drug without fully informing the purchaser at the time of the sale of the nature of the adulteration;</li>
                            <li>(b) any drug in any package which bears or has attached thereto any false or misleading statement, word, brand, label or mark purporting to indicate the nature, quality, strength, purity, composition, weight, origin, age or proportion of the article contained in the package or of any ingredient thereof;</li>
                            <li>(c) any drug containing any substance the addition of which is prohibited;</li>
                            <li>(d) any drug containing a greater proportion of any substance than is permitted;</li>
                            <li>(e) any drug for internal use which contains methyl alcohol, isopropyl alcohol or denatured alcohol; or</li>
                            <li>(f) to the prejudice of the purchaser any drug which is not of the nature or not of the substance or not of the quality of the drug demanded by the purchaser.</li>
                        </ul>
                        <p>(2) Where regulations made under this Act contain provisions prescribing the composition of, or prohibiting or restricting the addition of any substance to, any drug, a purchaser of the drug shall, unless the contrary be proved, be deemed for the purposes of this section to have demanded a drug complying with the provisions of such regulations.</p>
                        <p>(3) In proceedings under this section it shall not be a defence to allege that the purchaser bought for analysis or examination and therefore was not prejudiced.</p>
                        <p>(4) (Deleted by Act A1084).</p>
                    </div>
                    <div class="section" id="soda-sec11">
                        <h3>Section 11. Interference with official marks.</h3>
                        <p>Any person who without authority opens, alters, breaks, removes, or erases any mark, fastening, or seal placed by any officer or inspector in pursuance of this Act upon any drug or upon any package, place, door or opening containing or affording access to any drug commits an offence and shall be liable on conviction to a fine of five hundred ringgit.</p>
                    </div>
                    <div class="section" id="soda-sec12">
                        <h3>Section 12. General penalty.</h3>
                        <p>(1) Subject to subsection (2), any person who commits an offence against this Act or any regulation made under this Act for which no penalty is expressly provided shall be liable on conviction to a fine not exceeding twenty-five thousand ringgit or to imprisonment for a term not exceeding three years or to both, and for a second or subsequent offence he shall be liable on conviction to a fine not exceeding fifty thousand ringgit or to imprisonment for a term not exceeding five years or to both.</p>
                        <p>(2) Any body corporate who commits an offence against this Act or any regulation made under this Act for which no penalty is expressly provided shall be liable on conviction to a fine not exceeding fifty thousand ringgit, and for a second or subsequent offence it shall be liable on conviction to a fine not exceeding one hundred thousand ringgit.</p>
                    </div>
                    <div class="section" id="soda-sec13">
                        <h3>Section 13. Forfeiture of drugs upon conviction.</h3>
                        <p>In the case of any conviction under this Act the court shall order that any drug to which the conviction relates and any similar drug found on the defendant's premises or in his possession at the time of the commission of the offence, together with all packages vessels containing the same, shall be forfeited and shall be disposed of in such manner as the Chief Minister may direct.</p>
                    </div>
                    <div class="section" id="soda-sec14">
                        <h3>Section 14. Notification of conviction in newspapers.</h3>
                        <p>A notification of the name and occupation of any person who has been convicted of any offence against this Act together with his place or places of business, the nature of the offence and the fine, forfeiture, or other penalty inflicted shall, if the court so orders, be published in any newspaper circulating in Malaysia or in any part thereof, and the cost of such publication may be recovered from such person as a civil debt.</p>
                    </div>
                    <div class="section" id="soda-sec15">
                        <h3>Section 15. Adulteration.</h3>
                        <p>For the purposes of this Act any drug shall be deemed to be adulterated if-</p>
                        <ul>
                            <li>(a) it contains or is mixed or diluted with any substance which diminishes in any manner its beneficial properties as compared with such article in a pure and normal state and in an undeteriorated and sound condition or which in any other manner operates or may operate to the prejudice or disadvantage of the purchaser or consumer;</li>
                            <li>(b) any substance or ingredient has been extracted or omitted therefrom and by reason of such extraction or omission the beneficial properties of the article as sold are less than those of the article in its pure and normal state or the purchaser or consumer is or may be in any manner prejudiced;</li>
                            <li>(c) it contains or is mixed or diluted with any substance of lower commercial value than such article in a pure and normal state and in an undeteriorated and sound condition;</li>
                            <li>(d) if it contains any substance which renders the drug injurious to health; or</li>
                            <li>(e) it does not comply with the standard therefor prescribed by any regulations made under this Act.</li>
                        </ul>
                    </div>
                    <div class="section" id="soda-sec16">
                        <h3>Section 16. Sale by agent or servant.</h3>
                        <p>(1) For the purposes of this Act every person shall be deemed to sell any drug who sells the same either on his own account or as the agent or servant of any other person.</p>
                        <p>(2) In the case of any sale by an agent or servant his principal or employer shall be under the same liability as if he had effected the sale personally.</p>
                    </div>
                    <div class="section" id="soda-sec17">
                        <h3>Section 17. Presumptions as to sale for human or animal consumption or use.</h3>
                        <p>(1) When any drug is sold or exposed or offered for sale, it shall, unless the contrary is proved, be deemed to be sold or exposed or offered for sale for human or animal consumption or use.</p>
                        <p>(2) The purchase and sale of a sample of any drug under this Act for the purpose of analysis shall be deemed to be a purchase and sale of such drug for human or animal consumption or use unless the seller proves that the bulk from which such sample was taken was not offered, exposed, or intended for sale for human or animal consumption or use.</p>
                        <p>(3) For the purposes of this Act every person shall be deemed to sell or to intend to sell any drug if he sells or intends to sell for human or animal consumption or use any article of which such drug is constituent.</p>
                    </div>
                    <div class="section" id="soda-sec18">
                        <h3>Section 18. Proceedings for offences.</h3>
                        <p>(1) All proceedings in respect of an offence against this Act shall be taken in a summary manner before a Sessions Court or the Court of a First Class Magistrate.</p>
                        <p>(2) The summons in any such proceedings shall not be made returnable in less than fourteen days from the day on which it is served.</p>
                        <p>(3) There shall be served with the summons a copy of the analyst's certificate, if any, on which the prosecution is based.</p>
                        <p>(4) When any article of drug has been purchased or procured from any person for test purposes, no proceedings in respect of the sale thereof or of any offence against this Act shall be instituted after the expiration of sixty days from the time of purchasing or procuring the same.</p>
                    </div>
                    <div class="section" id="soda-sec19">
                        <h3>Section 19. No defence that offence not wilfully committed.</h3>
                        <p>In a prosecution for selling any drug contrary to this Act or of any regulations made thereunder it shall be no defence that the defendant did not act wilfully unless he also proves that he took all reasonable steps to ascertain that the sale of the article would not constitute an offence against this Act or against any regulations made thereunder.</p>
                    </div>
                    <div class="section" id="soda-sec20">
                        <h3>Section 20. Reliance on written warranty a good defence.</h3>
                        <p>(1) Subject to this section it shall be a good defence in any prosecution for an offence under section 10 if the defendant proves that-</p>
                        <ul>
                            <li>(a) he purchased the article sold by him in reliance on a written warranty or other written statement as to the nature of the articles purchased signed by or on behalf of the person from whom the defendant purchased the same; and</li>
                            <li>(b) he had no reason to believe that the article sold did not conform to such warranty or statement; and</li>
                            <li>(c) if the article had truly conformed to such warranty or statement, the sale of the article by the defendant would not have constituted the offence charged against him.</li>
                        </ul>
                        <p>(2) No warranty or other written statement given or made by a person resident outside Malaysia shall be any defence under this section unless the defendant proves that he had taken reasonable steps to ascertain and did in fact believe in the truth of the matters set forth in such warranty or statement.</p>
                        <p>(3) No warranty or other written statement shall be any defence in any prosecution unless the defendant has within seven days after service of the summons delivered to the prosecutor a copy of such warranty or statement with a written notice stating that he intends to rely thereon and specifying the name and address of the person from whom he received it and also within the same time sent by registered post a like notice of his intention to such person.</p>
                        <p>(4) When the defendant is a servant or agent of the person who purchased the article under such a warranty or written statement he shall be entitled to the benefit of this section in the same manner and to the same extent as his employer or principal would have been, if he had been the defendant; provided that the servant or agent further proves that he had no reason to believe that the article did not conform to the warranty or statement.</p>
                        <p>Penalty for false warranty</p>
                        <p>(5) Any person who in respect of an article of drug sold by him as principal or agent gives to the purchaser a false warranty in writing shall be liable on conviction to a fine not exceeding five hundred ringgit or for any subsequent offence to a fine not exceeding two thousand ringgit, unless he proves to the satisfaction of the court that when he gave the warranty he had reason to believe that the statements or descriptions contained therein were true.</p>
                    </div>
                    <div class="section" id="soda-sec21">
                        <h3>Section 21. Analyst's certificate to be prima facie evidence.</h3>
                        <p>(1) A certificate of analysis purporting to be under the hand of an analyst shall, on production thereof by the prosecutor, be sufficient evidence of the facts stated therein unless the defendant requires that the analyst be called as a witness, in which case he shall give notice thereof to the prosecutor not less than three clear days before the day fixed for the hearing of the summons.</p>
                        <p>(2) In like manner a certificate purporting to be under the hand of an analyst shall, on production thereof by the defendant be sufficient evidence of the facts stated therein unless the prosecutor requires that the analyst be called as a witness.</p>
                        <p>(3) A copy of such last-mentioned certificate shall be sent to the prosecutor at least three clear days before the day fixed for the hearing of the summons, and if it is not so sent the court may adjourn the hearing on such terms as it may think proper.</p>
                    </div>
                    <div class="section" id="soda-sec22">
                        <h3>Section 22. Court may order independent analysis.</h3>
                        <p>When a sample has been dealt with in accordance with section 7, the court before which any proceedings for an offence against this Act are heard shall on the request of either party to such proceedings, and may if it thinks fit without such request, order that the part of the sample retained by the officer be submitted to another analyst for analysis.</p>
                    </div>
                    <div class="section" id="soda-sec23">
                        <h3>Section 23. Non-disclosure.</h3>
                        <p>(1) No prosecutor or witness in any prosecution under this Act shall be compelled to disclose the fact that he received any information or the nature of such information or the name of any person who gave such information.</p>
                        <p>(2) No officer appearing as a prosecutor or witness shall be compelled to produce any confidential reports or documents made or received by him in his official capacity or to make any statement in relation thereto.</p>
                    </div>
                    <div class="section" id="soda-sec24">
                        <h3>Section 24. Recovery of fees and other expenses incidental to prosecution.</h3>
                        <p>(1) Where any person is convicted of an offence under this Act, the court may order that all fees and other expenses incident to the analysis of any drug in respect of which the conviction is obtained (including any analysis made under section 22 of this Act) shall be paid by the person convicted.</p>
                        <p>(2) All such fees and expenses shall be recoverable in the same manner as a fine is recoverable.</p>
                    </div>
                    <div class="section" id="soda-sec25">
                        <h3>Section 25. Appeal.</h3>
                        <p>Any person aggrieved by any sentence or order under this Act passed or made by a Sessions Court or a Magistrate's Court may appeal therefrom to the High Court:</p>
                        <p>Provided that where an accused person has pleaded guilty and has been convicted on such plea there shall be no appeal except as to the extent or legality of the sentence.</p>
                    </div>
                    <div class="section" id="soda-sec26">
                        <h3>Section 26. Power to make Regulations.</h3>
                        <p>(1) The Minister may make regulations for any of the following purposes:</p>
                        <ul>
                            <li>(a) to prescribe the standard of strength, weight, quality, or quantity of any drug or of any ingredient or component part thereof;</li>
                            <li>(b) to prohibit the addition of any specified thing or of more than the specified quantity or proportion thereof to any drug;</li>
                            <li>(c) to prohibit any modes of manufacture, preparation, or preservation of any drug;</li>
                            <li>(d) to secure the cleanliness and freedom from contamination of any drug in the course of its manufacture, preparation, storage, packing, carriage delivery or exposure for sale or sale and the cleanliness of places, receptacles, appliances, and vehicles used in such manufacture, preparation, storage, packing, carriage or delivery exposure for sale or sale and to secure the proper conduct of places in which the preparation or sale of drugs is carried on and for these purposes to require any person to submit to a medical examination;</li>
                            <li>(e) to provide for the licensing or registration of premises used for, or persons engaged or occupied in the manufacture, preparation, storage, packing, carriage, delivery, exposure for sale or sale of any drug and for these purposes to require photographs of persons registered or licensed;</li>
                            <li>(f) to prescribe the mode of labelling drugs sold in packages or otherwise and the matter to be contained or not to be contained in such labels;</li>
                            <li>(g) to prescribe the method of analysis of any drug and the form of certificate of analysis;</li>
                            <li>(h) to fix the fees to be paid in respect of the analysis of any drug by an analyst and for any copy of the result of any analysis and for any licence or registration issued or effected under this Act or under any regulation made thereunder;</li>
                            <li>(i) to prohibit or regulate the manufacture, sale, advertisement for sale, supply, importation or exportation of any articles of drugs and for this purpose to establish any body or authority;</li>
                            <li>(j) to require all ingredients contained in any medicine, proprietary, secret or otherwise, to be disclosed in the prescribed manner and form and with the prescribed particulars at or prior to the sale thereof;</li>
                            <li>(k) to prescribe a fine not exceeding fifty thousand ringgit or imprisonment for a term not exceeding five years or both for the breach of any regulation; and</li>
                            <li>(l) generally for carrying out the purposes of this Act.</li>
                        </ul>
                        <p>(2) Any such regulation may be made applicable either to drugs generally or to specified drugs only.</p>
                        <p>(3) Notwithstanding anything contained in any regulation made under this section it shall be lawful for any person at any time within twelve months after the date of the publication in the Gazette of such regulation to sell any drug the sale of which is otherwise lawful if he proves that at the said date such drug was part of the existing stock-in-trade in Malaysia of any person carrying on business there and that since the said date no act has been done whereby the said drug fails to conform to the requirements of the said regulation; and for the purpose of this subsection any goods purchased before the said date for importation into Malaysia shall be deemed to be part of the purchaser's stock-in-trade in Malaysia.</p>
                    </div>
                    <div class="section" id="soda-sec27">
                        <h3>Section 27. Extended application of Act.</h3>
                        <p>The provisions of this Act so far as they are applicable may be extended by regulations made under this Act to apply to tobbaco, cigars, cigarettes, snuff, soap, cosmetics and toilet preparations in like manner as the said provisions apply to drugs.</p>
                    </div>
                    <div class="section" id="soda-sec28">
                        <h3>Section 28. Analysts' fees.</h3>
                        <p>All fees received under this Act by any Government analyst shall be paid to the credit of the general revenue, or by any Municipal Analyst to the revenue of the Municipality concerned.</p>
                    </div>
                </div>
            </div>

            <div id="cdcr" class="act-section">
                <div class="act-section-header">
                    <h2>CONTROL OF DRUGS AND COSMETICS REGULATIONS 1984</h2>
                    <button class="toggle-sections-btn" aria-expanded="true" aria-controls="cdcr-sections-wrapper">Collapse Sections</button>
                </div>
                <div id="cdcr-sections-wrapper">
                    <div class="section" id="cdcr-arrangement">
                        <h3>ARRANGEMENT OF REGULATIONS</h3>
                        <ul>
                            <li>PART I-PRELIMINARY</li>
                            <li>Regulation 1. Citation and commencement.</li>
                            <li>Regulation 2. Interpretation.</li>
                            <li>PART II - THE DRUG CONTROL AUTHORITY</li>
                            <li>Regulation 3. Establishment and membership of the Authority.</li>
                            <li>Regulation 4. Alternate member.</li>
                            <li>Regulation 5. Meetings.</li>
                            <li>Regulation 6. Advisors.</li>
                            <li>PART III - REGISTRATION AND LICENSING</li>
                            <li>Regulation 7. Prohibition against manufacture, sale, supply, importation, possession and administration.</li>
                            <li>Regulation 7A.Prohibition regarding traditional medicine.</li>
                            <li>Regulation 7B. Presumption relating to registered product.</li>
                            <li>Regulation 8. Registration of product.</li>
                            <li>Regulation 9. Register of products.</li>
                            <li>Regulation 10. Declaration relating to imported product or cosmetic.</li>
                            <li>Regulation 11. Rejection, suspension or cancellation.</li>
                            <li>Regulation 12. Licences.</li>
                            <li>Regulation 13. Application for licence.</li>
                            <li>Regulation 14. Refusal of application for licence.</li>
                            <li>Regulation 15. Exemptions and savings.</li>
                            <li>Regulation 16. Certification.</li>
                            <li>Regulation 17. Revocation of licence.</li>
                            <li>Regulation 18. Appeal.</li>
                            <li>PART IIIA - NOTIFICATION OF COSMETICS</li>
                            <li>Regulation 18A. Prohibition to manufacture, sell, supply, import, possess or administer cosmetic.</li>
                            <li>PART IV - MANUFACTURE OF REGISTERED PRODUCTS OR NOTIFIED COSMETICS</li>
                            <li>Regulation 19. Personnel.</li>
                            <li>Regulation 20. Premises.</li>
                            <li>Regulation 21. Equipments.</li>
                            <li>Regulation 22. Manufacturing operations.</li>
                            <li>Regulation 23. Quality control department.</li>
                            <li>Regulation 24. Inspections.</li>
                            <li>Regulation 25. Distribution records.</li>
                            <li>PART V - MISCELLANEOUS</li>
                            <li>Regulation 26. Entry, inspection and seizure.</li>
                            <li>Regulation 27. Records of transactions.</li>
                            <li>Regulation 28. Reporting adverse reactions.</li>
                            <li>Regulation 29. Directions.</li>
                            <li>Regulation 30. General penalty.</li>
                            <li>Regulation 31. Power to grant exemption.</li>
                            <li>SCHEDULES</li>
                        </ul>
                    </div>

                    <div class="section" id="cdcr-part1-preliminary">
                        <h3>PART I - PRELIMINARY</h3>
                    </div>
                    <div class="section" id="cdcr-reg1">
                        <h3>Regulation 1. Citation and commencement.</h3>
                        <p>(1) These Regulations may be cited as the Control of Drugs and Cosmetics Regulations 1984.</p>
                        <p>(2) These Regulations shall come into force on such date as the Minister may appoint by notification in the Gazette, and the Minister may -</p>
                        <ul>
                            <li>(a) appoint one commencement date for drugs and a different commencement date for cosmetics; or</li>
                            <li>(b) appoint different commencement dates for different groups of products; or</li>
                            <li>(c) appoint different commencement dates for different provisions of these Regulations; or</li>
                            <li>(d) appoint different commencement dates for different parts of the Federation; or</li>
                            <li>(e) adopt any combination of the foregoing alternatives.</li>
                        </ul>
                    </div>
                    <div class="section" id="cdcr-reg2">
                        <h3>Regulation 2. Interpretation.</h3>
                        <p>In these Regulations, unless the context otherwise requires</p>
                        <p>"administer", in relation to any product, means-</p>
                        <ul>
                            <li>(a) give or apply to a human being or an animal, whether orally, by injection or by introduction into the body in any other way or by external application; and</li>
                            <li>(b) give or apply it either in existing state or it has been dissolved or dispersed in, or diluted or mixed with, some other substance used as a vehicle;</li>
                        </ul>
                        <p>"Authority" means the Drug Control Authority established under regulation 3;</p>
                        <p>"clinical trial" means an investigation or series of investigations on persons conducted by or under the direction and supervision of persons with scientific training or experience for the purpose of finding out about, or determining, the safety, effectiveness and other effects of any product;</p>
                        <p>"colour" means a substance used as an ingredient of a cosmetic product solely to give tonality to the product;</p>
                        <p>"contract manufacturer" means any person who manufactures any product on the order of another person to whom a manufacturer's licence has been issued under these Regulations;</p>
                        <p>"cosmetic" means any substance or preparation intended to be placed in contact with the various external parts of the human body (including epidermis, hair system, nails, lips and external genital organs) or with the teeth and the mucuos membranes of the oral cavity with a view exclusively or mainly to cleaning them, perfuming them, changing their appearance or correcting body odours, protecting them or keeping them in good condition;</p>
                        <p>"dental practitioner" means a person registered and having a valid annual or temporary practising certificate under the Dental Act 1971 [Act 51];</p>
                        <p>"drug" has the meaning assigned to it in the Ordinance but does not include a herbal remedy;</p>
                        <p>"flavour" means a substance used as an ingredient of a cosmetic product solely to impart taste to the product;</p>
                        <p>"fragrance" means a substance used as an ingredient of a cosmetic product solely to impart odour to the product;</p>
                        <p>"fully registered medical practitioner" means a person registered and having a valid annual or temporary practising certificate under the the Medical Act 1971[Act 50];</p>
                        <p>"herbal remedy" means any drug consisting of a substance or a mixture of substances produced by drying, crushing or comminuting, but without subjecting to any other process, a natural substance or substancs of plant, animal or mineral origin, or any part of such substance or substances;</p>
                        <p>"homeopathic medicine" means any pharmaceutical dosage form used in the homeopathic therapeutic system in which diseases are treated by the use of minute amount of such substances which are capable of producing in healthy person symptoms similar to those of the disease being treated;</p>
                        <p>"indigenous medicine" means a system of treatment and prevention of disease established through traditional use of naturally occuring substances;</p>
                        <p>"label" means a display of information, safety marks or features</p>
                        <ul>
                            <li>(a) accompanying a product; or</li>
                            <li>(b) on or attached to a container and package in relation to a product;</li>
                        </ul>
                        <p>"licence" means any of the licences issued under regulation 12;</p>
                        <p>"licenced importer" means a person to whom an import licence has been issued under these Regulations;</p>
                        <p>"licensed manufacturer" means a person to whom a manufacturer's licence has been issued under these Regulations, and includes a contract manufacturer;</p>
                        <p>"licensed wholesaler" means a person to whom a whosesaler's licence has been issued under these Regulations;</p>
                        <p>"life threatening illness" means a disease where the likelihood of death is high unless the course of the disease is interrupted;</p>
                        <p>"manufacture", in relation to any product includes</p>
                        <ul>
                            <li>(a) the making or assembling of the product;</li>
                            <li>(b) the enclosing or packing of the product in any container in a form suitable for administration or application, and the labelling of the container; and</li>
                            <li>(c) the carrying out of any process in the course of any or the foregoing activities;</li>
                        </ul>
                        <p>"pharmacist" means a person registered under the Registration of Pharmacists Ordinance 1951[ 62/51];</p>
                        <p>"possess", in relation to any product, includes keeping, storing, possessing for sale, possessing of or supply, possessing for self administration or administering to any person or animal or causing any person to administer to him;</p>
                        <p>"product" means-</p>
                        <ul>
                            <li>(a) a drug in a dosage unit or otherwise, for use wholly or mainly by being administered to one or more human beings or animals for a medicinal purpose; or</li>
                            <li>(b) a drug to be used as an ingredient of a preparation for a medicinal purpose;</li>
                            <li>(c) [Deleted P.U.(A) 477/2009];</li>
                        </ul>
                        <p>"product variant" means a product which is within a range of cosmetics produced by the same manufacturer that are similar in composition and are intended for the same use but are available in different colours, fragrance or flavours;</p>
                        <p>"registration certificate" - [Deleted P.U.(A) 257/2014]</p>
                        <p>"registered product" means a product currently registered in accordance with the provisions of these Regulations;</p>
                        <p>"Secretary" means the Secratary to the Authority appointed under regulation 3(6);</p>
                        <p>"traditional medicine" means any product used in the practice of indigenous medicine, in which the drug consist solely of one or more naturally occuring substance of a plant, animal or mineral, of parts thereof, in the unextracted or crude extract form, and a homeopathic medicine;</p>
                        <p>"veterinary practitioner" means a veterinary surgeon registered and having a valid annual practising certificate or temporary permit to practise under the Veterinary Surgeons Act 1974 [Act 147].</p>
                    </div>

                    <div class="section" id="cdcr-part2">
                        <h3>PART II - THE DRUG CONTROL AUTHORITY</h3>
                    </div>
                    <div class="section" id="cdcr-reg3">
                        <h3>Regulation 3. Establishment and membership of the Authority.</h3>
                        <p>(1) An authority to be called the Drug Control Authority is established for the purposes of these Regulations.</p>
                        <p>(2) The Authority shall consist of the following members:</p>
                        <ul>
                            <li>(a) the Director-General of Health;</li>
                            <li>(b) the Director of Pharmaceutical Services;</li>
                            <li>(c) the Director of the National Pharmaceutical Control Bureau; and</li>
                            <li>(d) eight other members to be appointed by the Minister.</li>
                        </ul>
                        <p>(3) Members appointed under subregulations (2)(d) shall be the following persons:</p>
                        <ul>
                            <li>(a) a consultant physician in the public service;</li>
                            <li>(b) a pharmacist in the public service;</li>
                            <li>(c) three persons from any local universities with expertise in pharmaceutical sciences;</li>
                            <li>(d) two fully registered medical practitioners; and</li>
                            <li>(e) a veterinary practitioner in the public service.</li>
                        </ul>
                        <p>(4) Subject to subregulation (5), a member appointed under subregulation (2)(d) shall, unless he sooner resigns, hold office for a period of three years but shall be eligible for reappointment.</p>
                        <p>(5) The Minister may, at any time and without assigning any reason, suspend or terminate the appointment of any member appointed under subregulation (2)(d).</p>
                        <p>(6) The Minister shall, after consultation with the Authority, appoint a pharmacist in the public service to be Secretary to the Authority.</p>
                        <p>(7) The Secretary shall not be a member of the Authority.</p>
                        <p>(8) Any appointment to, or suspension or termination of, membership under these Regulation shall be published in the Gazette.</p>
                    </div>
                    <div class="section" id="cdcr-reg4">
                        <h3>Regulation 4. Alternate member.</h3>
                        <p>(1) The Minister may appoint in respect of each member appointed under regulation 3(2)(d) an alternate member who shall be similarly qualified as the substantive member, as provided in regulation 3 (3).</p>
                        <p>(2) An alternate member may attend meetings of the Authority or otherwise act for the substantive member when the substantive member is temporarily unable to act.</p>
                        <p>(3) An alternate member attending any meeting of the Authority or acting for the substantive member under subregulation (2) shall be deemed for all purposes to be a member of the Authority.</p>
                    </div>
                    <div class="section" id="cdcr-reg5">
                        <h3>Regulation 5. Meetings.</h3>
                        <p>(1) Subject to subregulation (2), the Director-General of Health shall be the Chairman of the Authority and shall preside at all meetings of the Authority.</p>
                        <p>(2) The Director of Pharmaceutical Services shall be the alternate Chairman and shall preside at meetings of the Authority in the absence of the Chairman.</p>
                        <p>(3) The chairman of a meeting shall have an original vote and, in the event of an equality of votes, a second or casting vote.</p>
                        <p>(4) Four members of the Authority including the chairman shall form a quorum.</p>
                        <p>(5) The Authority shall meet at such times and places as the Chairman may determine.</p>
                        <p>(6) The Authority may invite any person appointed under regulation 6 or any other person to attend any meeting of the Authority but such persons shall not have the right to vote at the meeting.</p>
                        <p>(7) They may be paid to members of the Authority, to the Secretary, to persons invited under subregulation (6), to attend any meeting of the Authority and to persons appointed under regulation 6 such allowances and other expenses as may be approved by the Government from time to time and such allowances and expenses shall be payable out of the general revenues of the Government.</p>
                        <p>(8) Subject to this regulations, the Authority shall regulate its own procedure.</p>
                        <p>(9) No action or proceeding of the Authority shall be questioned on the ground -</p>
                        <ul>
                            <li>(a) of the existence of any vacancy in the membership, or any defect in the constitution of the Authority; or</li>
                            <li>(b) of any ommission, defect or irregularity in procedure not affecting the merits of the case.</li>
                        </ul>
                    </div>
                    <div class="section" id="cdcr-reg6">
                        <h3>Regulation 6. Advisors.</h3>
                        <p>The Authority may appoint a person or persons as it may think necessary as advisors for the purpose of giving it advice when discharging any of its functions.</p>
                    </div>

                    <div class="section" id="cdcr-part3">
                        <h3>PART III - REGISTRATION AND LICENSING</h3>
                    </div>
                    <div class="section" id="cdcr-reg7">
                        <h3>Regulation 7. Prohibition against manufacture, sale, supply, importation, possession and administration.</h3>
                        <p>(1) Except as otherwise provided in these Regulations, no person shall manufacture, sell, supply, import or possess or administer any product unless -</p>
                        <ul>
                            <li>(a) the product is a registered product; and</li>
                            <li>(b) the person holds the appropriate licence required and issued under these Regulations.</li>
                        </ul>
                        <p>(1A) Notwithstanding subregulation (1), no person shall manufacture, sell, supply, import, possess or administer any product-</p>
                        <ul>
                            <li>(a) which is a mixture of a registered product with another substance that is not intended for reconstitution;</li>
                            <li>(b) which is a mixture of a registered product with another registered product;</li>
                            <li>(c) which is labelled with an additional name other than the name registered by the Authority;</li>
                            <li>(d) which is labelled with a registration number or listing number which belongs to a particular registered product;</li>
                            <li>(e) which is labelled with any words, symbols or letters purporting to be true but which is otherwise;</li>
                            <li>(f) whose label is not complying to the directives or guidelines issued under regulation 29; or</li>
                            <li>(g) the registration of which has been suspended or cancelled by the Authority.</li>
                            <li>(h) which contains any metal contaminant unless naturally occurs, which contained in any traditional medicine as specified in column (1) of Table 1 to the Schedule in a proportion not greater than the maximum permitted proportion specified opposite the substance in column (2) of the Table.</li>
                        </ul>
                        <p>(1B) No person shall possess any written information, statement or document which describes the indication or use of a product other than the indication or use as approved in its registration by the Authority.</p>
                        <p>(2) Notwithstanding any other provisions of these Regulations</p>
                        <ul>
                            <li>(a) the Director of Pharmaceutical Services may, on application with a fee of RM100.00, issue a written approval to any person who is not the product registration holder to import any product-
                                <ul>
                                    <li>(i) where he is satisfied that the particular product is in all respects the same as a registered product; and</li>
                                    <li>(ii) subject to the terms and conditions as he may impose.</li>
                                </ul>
                            </li>
                            <li>(b) No person shall import any product to be assembled, enclosed, packed or labelled for the sole purpose of re-exporting the product unless the person is issued with a written approval by the Director of Pharmaceutical Services, subject to the terms and conditions as he may impose.</li>
                        </ul>
                        <p>(3) The provisions of subregulations (1) relating to importation do not apply to any person arriving in the Federation from a place outside of Federation who imports, as part of his personal luggage, any product meant solely for his use or for the use of his family in a quantity not exceeding that which may be reasonably required for one month's use by one person, or to any officer of the Government importing any product in the course of his duty, or to any person who, in accordance with the written consent of the Authority, brings any product into the Federation in transit.</p>
                        <p>(4) In subregulations (3), "in transit" means taken or sent from any country and brought into the Federation by land, air, or water, whether or not landed or transhipped in the Federation, for the sole purpose of being carried to another country either by the same or another conveyance.</p>
                    </div>
                    <div class="section" id="cdcr-reg7a">
                        <h3>Regulation 7A. Prohibition regarding traditional medicine.</h3>
                        <p>No person shall manufacture, sell, supply, import, possess or administer any traditional medicine which contain any substance as set out in Table II to the Schedule.</p>
                    </div>
                    <div class="section" id="cdcr-reg7b">
                        <h3>Regulation 7B. Presumption relating to registered product.</h3>
                        <p>When a product refers to an existing registered product, the product shall not be deemed to be a registered product if the product-</p>
                        <ul>
                            <li>(a) contains any ingredient other than the ingredient of the existing registered product; or</li>
                            <li>(b) is labelled with a label other than a label of the existing registered product,</li>
                        </ul>
                        <p>as approved by the Authority.</p>
                    </div>
                    <div class="section" id="cdcr-reg8">
                        <h3>Regulation 8. Registration of product.</h3>
                        <p>(1) The Authority may, on application made in such manner or form as it may require, register any product subject to such conditions as it may impose.</p>
                        <p>(2) Every application for the registration of a product shall be accompanied by-</p>
                        <ul>
                            <li>(a) a processing fee of RM500.00 for traditional medicines;</li>
                            <li>(b) a processing fee of RM50.00 for each product variant; or</li>
                            <li>(c) a processing fee of RM1000.00 for products other than traditional medicines; and</li>
                            <li>(d) such documents, items, samples, particulars or information as the Authority may require.</li>
                        </ul>
                        <p>(3) The Authority may charge any applicant such costs as it may incur for the purpose of carrying out any evaluation or investigation prior to the registration of any product.</p>
                        <p>(4) The processing fee and such costs as may be incurred by the Authority under subregulation (3) shall not be refundable in the event of the application being rejected under regulation 11.</p>
                        <p>(5) Any change in any document, item, sample, particulars or information mentioned in subregulation (2) shall be notified in writting by the applicant to the Authority within fourteen days from the date of such change.</p>
                        <p>(6) Subject to regulation 11, the period of registration of a product shall be as notified by the Authority and where so notified, the registration shall be valid until the end of the notified period.</p>
                        <p>(7) Subject to regulation 11, where the period of registration of a product is not notified the registration shall be valid until it is cancelled.</p>
                        <p>(8) Upon registration of a product, the Authority shall notify the product registration holder and assign a product registration number or a product listing number to each registered product.</p>
                        <p>(9) Any person who knowingly supplies any false or misleading information to the Authority in connection with his application for the registration of a product commits an offence.</p>
                    </div>
                    <div class="section" id="cdcr-reg9">
                        <h3>Regulation 9. Register of products.</h3>
                        <p>(1) The Secretary shall keep and maintain a register of the products registered; and separate registers may be kept and maintained for drugs.</p>
                        <p>(2) The register shall contain -</p>
                        <ul>
                            <li>(a) the name under which the product is registered;</li>
                            <li>(b) the content and quantity of the active ingredients;</li>
                            <li>(c) the name and address of the manufacturer;</li>
                            <li>(d) the name and address of the product registration holder;</li>
                            <li>(e) product registration number or product listing number; and</li>
                            <li>(f) the date of issue and expiry of the registration certificate, if any.</li>
                        </ul>
                        <p>(3) Any person may, upon written application to the Secretary and upon payment of a fee of \$5.00, inspect the register or registers kept under subregulation (1).</p>
                        <p>(4) A certificate issued by the Secretary or the officer who is responsible for the registration of any product shall be prima facie evidence of the facts stated.</p>
                    </div>
                    <div class="section" id="cdcr-reg10">
                        <h3>Regulation 10. Declaration relating to imported product or cosmetic.</h3>
                        <p>(1) The Authority may, in the case of an imported product, require any person applying for the registration of the imported product to furnish a written declaration made by or on behalf of the manufacturer of the imported product that all requirement governing the manufacture of the product imposed by the law of the country of manufacture have been complied with.</p>
                        <p>(2) The Director of Pharmaceutical Services may, in the case of an imported cosmetic, require any person applying for the issuance of a notification note for the imported cosmetic to furnish a written declaration made by or on behalf of the manufacturer of the imported cosmetic that all requirement governing the manufacture of the cosmetic imposed by the law of the country of manufacture have been complied with.</p>
                    </div>
                    <div class="section" id="cdcr-reg11">
                        <h3>Regulation 11. Rejection, suspension or cancellation.</h3>
                        <p>(1) The Authority may, at any time and without assigning any reason, reject, suspend or cancel the registration of any product and may amend the conditions to which such registration is subject.</p>
                        <p>(2) Subject to subregulation (3), any suspension or cancellation of the registration of any product under subregulation (1) shall similarly and at the same time affect any licence issued under these Regulations relating to that product.</p>
                        <p>(3) Notwithstanding subregulation (2), where a licence issued under these Regulations relates to several registered products, the suspension or cancellation of the registration of any product under subregulation (1) shall not affect the position of other registered products listed in the licence.</p>
                    </div>
                    <div class="section" id="cdcr-reg12">
                        <h3>Regulation 12. Licences.</h3>
                        <p>(1) The Director of Pharmaceutical Services may, subject to the provisions of these Regulations, issue any of the following licences subject to such conditions as he may impose:</p>
                        <ul>
                            <li>(a) a manufacturer's licence in Form 2 in the Schedule, authorising the licensee to manufacture the registered products in the premises specified in the licence and to sell by wholesale or supply the products;</li>
                            <li>(b) a wholesaler's licence in Form 3 in the Schedule, authorising the licensee to sell by wholesale or supply the registered products from the address of the business premises specified in the licence;</li>
                            <li>(c) a clinical trial import licence in Form 4 in the Schedule, authorising the licensee to import any product for purposes of clinical trials, notwithstanding that the product is not a registered product;</li>
                            <li>(d) an import licence in Form 5 in the Schedule, authorising the licensee to import and sell by wholesale or supply the registered products from the address of the premises specified in the licence.</li>
                        </ul>
                        <p>(2) Provided that, any number of registered products may be included in any licence other than a clinical trial import licence, which shall include only one product.</p>
                        <p>(3) Subject to subregulation (2), the Director of Pharmaceutical Services may, on application by the licensee, add to the registered products included in any licence other than a clinical trial import licence, and make such addition or amendment to the conditions of the licence as are rendered necessary by the addition of the other registered products.</p>
                        <p>(4) Subject to regulation 17, a licence issued under these Regulations, other than a clinical trial import licence, shall be valid for one year.</p>
                        <p>(5) Subject to regulation 17, a clinical trial import licence shall be valid for such period, not exceeding three years from the date of issue of the licence, as may be specified in the licence.</p>
                        <p>(6) Every licence shall be personal to the licensee named in the licence and shall not be transferable to another person.</p>
                    </div>
                    <div class="section" id="cdcr-reg13">
                        <h3>Regulation 13. Application for licence.</h3>
                        <p>(1) An application for licence under these Regulations shall be made in such manner or form as the Director of Pharmaceutical Services may require and shall be accompanied with a processing fee of RM1000.00 in the case of an application for a manufacturer's licence and RM500.00 in the case of an application for any other licence.</p>
                        <p>(2) The processing fee shall not be refundable.</p>
                        <p>(3) The applicant for a licence shall furnish such documents, particulars or information as the Director of Pharmaceutical Services may require.</p>
                        <p>(4) Any person who knowingly supplies any false or misleading information to the Director of Pharmaceutical Services in connection with his application for a licence commits an offence.</p>
                    </div>
                    <div class="section" id="cdcr-reg14">
                        <h3>Regulation 14. Refusal of application for licence.</h3>
                        <p>The Director of Pharmaceutical Services may, if he thinks fit and without assigning any reason, refuse any application for a licence.</p>
                    </div>
                    <div class="section" id="cdcr-reg15">
                        <h3>Regulation 15. Exemptions and savings.</h3>
                        <p>(1) Any person who wishes to import any product or cosmetic for the purpose of research in a school of pharmacy or a research or training institution or in order to obtain samples for purposes of registration or issuance of a notification note may on application be exempted by the Director of Pharmaceutical Services from the provisions of regulation 7(1) or regulation 18A.</p>
                        <p>(2) The requirement of regulation 7(1) as regards a licence to supply or manufacture does not apply to the dispensing, of any drug for the purpose of it being used for medical treatment of a particular patient or animal, by the following persons and in the following circumstances:</p>
                        <ul>
                            <li>(a) a pharmacist or a person working under the immediate personal supervision of a pharmacist in a retail pharmacy;</li>
                            <li>(b) a person acting in the course of his duties who is employed in a hospital or dispensary maintained by the Federal or any State Government or out of public funds or by a charity approved for the purposes of section 9(1)(b) of the Poisons Ordinance 1952 or in an estate hospital and who is authorised in writing as provided in that section; and</li>
                            <li>(c) a fully registered medical practitioner or a dental practitioner or a veterinary practitioner or a person working under the imediate personal supervision of such a practitioner if the drug in question is for the use of such practitioner or of his patients.</li>
                        </ul>
                        <p>(3) Regulation 7(1)(a) shall not apply to any drug manufactured by persons and in the circumstances described in subregulation (2) if the drug is manufactured for the purpose of dispensing.</p>
                        <p>(4) A school of pharmacy or any research or training institution which wishes to manufacture any product or cosmetic for teaching and research purposes may on application be exempted by the Director of Pharmaceutical Services from the provisions of regulation 7(1) or regulation 18A.</p>
                        <p>(5) Any person who wishes to manufacture any product solely for the purpose of producing samples for clinical trials, for registration or issuance of notification note under these Regulation may on application be exempted by the Director of Pharmaceutical Services from the provisions of regulation 7(1) or regulation 18A.</p>
                        <p>(6) Any person who wishes to import or manufacture any product solely for the purpose of treatment of any person suffering from a life-threatening illness may on application be exempted by the Director of Pharmaceutical Services from the provision of regulation 7(1) subject to such condition or restrictions as he may impose in such exemption.</p>
                    </div>
                    <div class="section" id="cdcr-reg16">
                        <h3>Regulation 16. Certification.</h3>
                        <p>(1) The Director of Pharmaceutical Services may issue such certification on any matter relating to any product where such certification is required by any country importing such a product.</p>
                        <p>(2) A fee of RM50.00 is payable on the issue of such certification.</p>
                    </div>
                    <div class="section" id="cdcr-reg17">
                        <h3>Regulation 17. Revocation of licence.</h3>
                        <p>The Director of Pharmaceutical Services may, at any time and without assigning any reason, revoke any licence issued under these Regulations and may amend the conditions of the licence.</p>
                    </div>
                    <div class="section" id="cdcr-reg18">
                        <h3>Regulation 18. Appeal.</h3>
                        <p>Any person aggrieved by any decision of the Authority or the Director of Pharmaceutical Services under these Regulations may make a written appeal to the Minister within fourteen days from the date the decision is made known to him and any decision of the Minister made on an appeal shall be final.</p>
                    </div>

                    <div class="section" id="cdcr-part3a">
                        <h3>PART IIIA - NOTIFICATION OF COSMETICS</h3>
                    </div>
                    <div class="section" id="cdcr-reg18a">
                        <h3>Regulation 18A. Prohibition to manufacture, sell, supply, import, possess or administer cosmetic.</h3>
                        <p>(1) No person shall manufacture, sell, supply, import, possess or administer any cosmetic-</p>
                        <ul>
                            <li>(a) unless the cosmetic is a notified cosmetic;</li>
                            <li>(b) unless he is the person responsible for placing the notified cosmetic in the market or a person authorized in accordance with the notification note which is issued by the Director of Pharmaceutical Services;</li>
                            <li>(c) which is a mixture of a notified cosmetic and any poison within the meaning of the Poisons Act 1952;</li>
                            <li>(d) which is a mixture of a notified cosmetic with a registered product;</li>
                            <li>(e) which is labelled with any additional name other than the name notified by the Director of Pharmaceutical Services;</li>
                            <li>(f) which label does not comply with the directives or guidelines issued by the Director of Pharmaceutical Services;</li>
                            <li>(g) which notification as a notified cosmetic has been cancelled by the Director of Pharmaceutical Services; or</li>
                            <li>(h) which is labelled with any word, symbol, letter, figure, mark or safety feature purporting to be true but which is otherwise.</li>
                        </ul>
                        <p>(2) For the purpose of subregulation (1), "notified cosmetic" means a cosmetic as specified in the notification note issued by the Director of Pharmaceutical Services, in the manner as he deems fit.</p>
                        <p>(3) The provisions of subregulation (1) do not apply to any person-</p>
                        <ul>
                            <li>(a) arriving in the Federation from a place outside Federation who imports, as part of his personal luggage, any cosmetic solely for his personal use or for the use of his family in a quantity not exceeding that which may be reasonably required for one month's use by one person; or</li>
                            <li>(b) who manufactures any cosmetic for the purpose of export only or for assessing the market acceptance if a written approval with or without conditions is issued by the Director of Pharmaceutical Services; or</li>
                            <li>(c) who imports any cosmetic-
                                <ul>
                                    <li>(i) for assessing the market acceptance;</li>
                                    <li>(ii) to be assembled, enclosed, packed or labelled for the sole purpose of re-exporting;</li>
                                    <li>(iii) in transit; or</li>
                                    <li>(iv) to be sold or supplied in the free-trade zone or international carriage by ships, aircrafts or other forms of international public transport entering or leaving Malaysia,</li>
                                </ul>
                                if a written approval with or without conditions is issued by the Director of Pharmaceutical Services.
                            </li>
                        </ul>
                        <p>(3A) In addition to subregulation (3), paragraph (1)(b) does not apply to the administration, possession, and sale or supply of any notified cosmetic.</p>
                        <p>(4) In subregulation (3), "in transit" means taken or sent from any country and brought into the Federation by land, air, or water, whether or not landed or transhipped in the Federation, for the sole purpose of being carried to another country either by the same or another conveyance.</p>
                        <p>(5) Any person responsible for placing the notified cosmetic in the market may apply for the issuance of notification note in such manner as determined by the Director of Pharmaceutical Services and shall be accompanied with a processing fee as it may require.</p>
                        <p>(6) The processing fee shall not be refundable.</p>
                        <p>(7) The Director of Pharmaceutical Services may issue a notification note to the person responsible for placing the notified cosmetic in the market, subject to such conditions as he may impose.</p>
                        <p>(7A) The Director of Pharmaceutical Services may, at any time and without assigning any reason, reject any application for the issuance of notification note.</p>
                        <p>(8) The Director of Pharmaceutical Services may, at any time and without assigning any reason, cancel the notification note of any cosmetic and may amend any conditions to which the notification note is subject.</p>
                        <p>(9) The person responsible for placing the notified cosmetic in the market or the authorized person shall report to the Director of Pharmaceutical Services any serious or high incidences of adverse events that occurred regardless of the source and the report shall be in the manner as determined by him.</p>
                        <p>(10) The person responsible for placing the notified cosmetic in the market or the authorized person shall comply to any directives or guidelines issued and any conditions imposed by the Director of Pharmaceutical Services.</p>
                        <p>(11) The person responsible for placing the notified cosmetic in the market or the authorized person shall maintain proper records in the manner as determined by the Director of Pharmaceutical Services.</p>
                        <p>(12) Where any notified cosmetic is found to have contravened or reasonably suspected to have contravened any provision of these Regulations, the Director of Pharmaceutical Services may, by directive in writing, order the person responsible for placing the notified cosmetic in the market, or the authorized person to recall, remove, or withdraw the notified cosmetic from any premises within such time as may be specified in the directive.</p>
                        <p>(13) Notwithstanding subregulation (12), it shall be the duty of the person responsible for placing the notified cosmetic in the market, or the authorized person if he knows or has reason to believe or it has come to his knowledge that the notified cosmetic has contravened any of the directives or guidelines of the Director of Pharmaceutical Services, to recall, remove or withdraw such notified cosmetic with immediate effect.</p>
                        <p>(14) No person shall possess or publish any label, information, pictorial, statement or document which describes the claim of the cosmetics otherwise than in the manner as determined in the directives or guidelines issued by the Director of Pharmaceutical Services.</p>
                        <p>(15) Any person who contravenes subregulations (1), (3), (9), (10), (11), (13) and (14) commits an offence.</p>
                    </div>

                    <div class="section" id="cdcr-part4">
                        <h3>PART IV - MANUFACTURE OF REGISTERED PRODUCTS OR NOTIFIED COSMETICS</h3>
                    </div>
                    <div class="section" id="cdcr-reg19">
                        <h3>Regulation 19. Personnel.</h3>
                        <p>A licensed manufacturer shall ensure that all personnel employed at all levels of manufacture -</p>
                        <ul>
                            <li>(a) possess suitable qualifications required for their job;</li>
                            <li>(b) have adequate experience and are technically competent;</li>
                            <li>(c) are regularly trained during their employment for the purposes of keeping up to date with any advances or changes; and</li>
                            <li>(d) are medically examined regularly.</li>
                        </ul>
                    </div>
                    <div class="section" id="cdcr-reg20">
                        <h3>Regulation 20. Premises.</h3>
                        <p>(1) A registered product or notified cosmetic shall be manufactured, processed, packed, labelled and tested in the premises which are in accordance with the standards set by-</p>
                        <ul>
                            <li>(a) in the case of a registered product, the Authority; or</li>
                            <li>(b) in the case of a notified cosmetic, the Director of Pharmaceutical Services.</li>
                        </ul>
                        <p>(2) Adequate storage areas shall be provided so that all starting, rejected and returned materials, oг intermediate or finished registered products or notified cosmetic, are adequately separated.</p>
                        <p>(3) Manufacturing premises shall be maintained in good and sanitary conditions; there shall be a sanitation programme for the maintenance of the premises in these conditions and records of the performance of the programme shall be kept.</p>
                    </div>
                    <div class="section" id="cdcr-reg21">
                        <h3>Regulation 21. Equipments.</h3>
                        <p>(1) Manufacturing and testing equipments shall be designed, placed and maintained in such a way so as to -</p>
                        <ul>
                            <li>(a) be suitable for their intended use;</li>
                            <li>(b) facilitate thorough cleaning whenever necessary;</li>
                            <li>(c) minimise any contamintaion of registered products or notified cosmetic and their containers during manufacture; and</li>
                            <li>(d) minimise the risks of confusion or omission of any manufacturing steps.</li>
                        </ul>
                        <p>(2) A licensed manufacturer or manufacturer of the notified cosmetic shall -</p>
                        <ul>
                            <li>(a) ensure all weighing, measuring and recording equipments are maintained in good working conditions and are regularly calibrated;</li>
                            <li>(b) where suitable, have manufacturing steps monitored by recording devices;</li>
                            <li>(c) ensure all manufacturing equipments are thoroughly and regularly cleaned in accordance with such written specifications as the Authority may determine; and</li>
                            <li>(d) ensure records of the matters in paragraphs (a), (b) and (c) are kept and maintained.</li>
                        </ul>
                    </div>
                    <div class="section" id="cdcr-reg22">
                        <h3>Regulation 22. Manufacturing operations.</h3>
                        <p>Manufacturing operations shall be carried out in accordance with such requirements as may be determined by the Authority.</p>
                    </div>
                    <div class="section" id="cdcr-reg23">
                        <h3>Regulation 23. Quality control department.</h3>
                        <p>(1) A licensed manufacturer or manufacturer of the notified cosmetic shall establish a quality control department under the supervision of a suitably qualified person.</p>
                        <p>(2) A quality control department shall -</p>
                        <ul>
                            <li>(a) control all materials used in the manufacturing process;</li>
                            <li>(b) monitor the quality aspects of all manufacturing steps; and</li>
                            <li>(c) control the quality and stability of the finished registered products or notified cosmetics.</li>
                        </ul>
                        <p>(3) For the purposes of this regulation, a licensed manufacturer shall provide such facilities as may be necessary for a quality control department to discharge its duties.</p>
                    </div>
                    <div class="section" id="cdcr-reg24">
                        <h3>Regulation 24. Inspections.</h3>
                        <p>For the purposes of this Part, a licensed manufacturer or manufacturer of the notified cosmetic shall conduct regular inspections of his manufacturing and quality control activities.</p>
                    </div>
                    <div class="section" id="cdcr-reg25">
                        <h3>Regulation 25. Distribution records.</h3>
                        <p>A licensed manufacturer or manufacturer of the notified cosmetic shall maintain proper records of every batch of finished registered products or notified cosmetics distributed to enable the complete and rapid recall of the registered product or notified cosmetic if necessary.</p>
                    </div>

                    <div class="section" id="cdcr-part5">
                        <h3>PART V - MISCELLANEOUS</h3>
                    </div>
                    <div class="section" id="cdcr-reg26">
                        <h3>Regulation 26. Entry, inspection and seizure.</h3>
                        <p>(1) For purposes of investigating the commission of any offence under these Regulations, any officer or inspector may, at all reasonable times, enter any premises used for or connected with the manufacture, sale, supply, possess, administer or import of any product or notified cosmetic for the purposes of inspecting</p>
                        <ul>
                            <li>(a) the product or notified cosmetic with which the premises are concerned;</li>
                            <li>(b) the premises and the operations carried out in the premises; and</li>
                            <li>(c) any licence, registration certificate, the notification note, record or document required under these Regulations.</li>
                        </ul>
                        <p>and every licensed person and every agent and servant of the licensed person, and the person responsible for placing the notified cosmetic in the market shall afford every assistance required by the officer or inspector and shall, on demand by the officer or inspector, produce any product or notified cosmetic or any licence, registration certificate, record or document required under these Regulations.</p>
                        <p>(2) Any officer or inspector may seize any product or cosmetic in respect of which he reasonably believes that an offence under these Regulations, or any breach of the conditions subject to or upon which any licence or registration has been granted or effected, or any notification note has been issued, has been or being committed and any plant, equipment, book, document or other article which he reasonable believes would furnish evidence of the commission of such offence or breach.</p>
                    </div>
                    <div class="section" id="cdcr-reg27">
                        <h3>Regulation 27. Records of transactions.</h3>
                        <p>(1) Every licensed wholesaler and importer or person responsible for placing the notified cosmetic in the market shall maintain proper records of each transaction involving the registered product, or notified cosmetic showing the particulars specified in this regulation, or any directive or guideline issued by the Director of Pharmaceutical Services for a period of not less than five years from the date of the transaction.</p>
                        <p>(2) In the case of a licensed wholesaler, the records shall show the date of sale or supply, the name and address of the purchaser, the name and quantity of the registered product sold, the registration reference of the product and the number of the invoice or delivery order.</p>
                        <p>(3) In the case of a licensed importer, or an importer of any cosmetic the records shall show the date of importation, the name and address of the supplier, the name and quantity of the registered product or notified cosmetic imported, the number of the bill of lading, the date of any sale or supply made and the name and address of the purchaser.</p>
                    </div>
                    <div class="section" id="cdcr-reg28">
                        <h3>Regulation 28. Reporting adverse reactions.</h3>
                        <p>The product registration holder or any person who possesses any registered product shall inform immediately the Director of Pharmaceutical Services of any adverse reactions arising from the use of the registered product.</p>
                    </div>
                    <div class="section" id="cdcr-reg29">
                        <h3>Regulation 29. Directions.</h3>
                        <p>(1) The Director of Pharmaceutical Services may issue written directives or guidelines to any person or a group of persons as he thinks necessary for the better carrying out of the provisions of these Regulations and which in particular relate to-</p>
                        <ul>
                            <li>(a) product quality, safety and efficacy;</li>
                            <li>(b) labelling;</li>
                            <li>(c) change of particulars of a product;</li>
                            <li>(d) transfer of licences;</li>
                            <li>(e) manufacturing;</li>
                            <li>(f) storage includes requirements as to containers;</li>
                            <li>(g) retailing;</li>
                            <li>(h) promotion of sale including product information;</li>
                            <li>(i) product recall;</li>
                            <li>(j) product disposal;</li>
                            <li>(k) the cost of product recall or product disposal;</li>
                            <li>(l) clinical trials; or</li>
                            <li>(m) records and statistics pertaining to manufacture, sale, supply, import or export of any products.</li>
                        </ul>
                        <p>(2) Any person who contravenes any directives or guidelines issued by the Director of Pharmaceutical Services under subregulation (1) commits an offence.</p>
                    </div>
                    <div class="section" id="cdcr-reg30">
                        <h3>Regulation 30. General penalty.</h3>
                        <p>(1) Any person who contravenes any of the provisions of these Regulations or any condition of any licence issued under these Regulations or any condition subject to which a product is registered under these Regulations commits an offence.</p>
                        <p>(2) [Deleted by P.U.(A) 186/2001]</p>
                    </div>
                    <div class="section" id="cdcr-reg31">
                        <h3>Regulation 31. Power to grant exemption.</h3>
                        <p>The Minister may, after consultation with the Authority, exempt any person or class of persons by notification in the Gazette from any of the provisions of these Regulations subject to such conditions or restrictions as he may impose in such exemption.</p>
                    </div>
                </div>
            </div>
        </div> </div> <button id="scroll-to-top" title="Go to top" aria-label="Scroll to top">&#8679;</button>

    <script>
        let originalContentHTML = '';
        let matches = [];
        let currentMatchIndex = -1;
        const tocToggleButton = document.getElementById('toc-toggle-button');
        const tocSidebar = document.getElementById('toc-sidebar');
        const body = document.body;
        const contentElement = document.getElementById('content');

        const DEFAULT_FONT_SIZE = 16; // px
        const FONT_SIZE_STEP = 1; // px
        const MIN_FONT_SIZE = 12;
        const MAX_FONT_SIZE = 24;

        // --- Utility ---
        function escapeRegExp(string) { return string.replace(/[.*+?^${}()|[\]\\]/g, '\\$&'); }

        function generateId(text, basePrefix = 'toc') {
            const cleanText = text.toString().trim().toLowerCase()
                .replace(/\s+/g, '-') // Replace spaces with hyphens
                .replace(/[^\w-]+/g, ''); // Remove non-alphanumeric characters except hyphens
            return `${basePrefix}-${cleanText}`.replace(/-+/g,'-'); // Avoid multiple hyphens
        }

        // --- Theme Toggle ---
        function applyTheme(theme) {
            if (theme === 'dark') {
                body.classList.add('dark-theme');
                document.getElementById('theme-toggle').textContent = 'Light Mode';
            } else {
                body.classList.remove('dark-theme');
                document.getElementById('theme-toggle').textContent = 'Dark Mode';
            }
        }
        function initThemeToggle() {
            const themeToggleBtn = document.getElementById('theme-toggle');
            themeToggleBtn.addEventListener('click', () => {
                const currentTheme = body.classList.contains('dark-theme') ? 'dark' : 'light';
                const newTheme = currentTheme === 'dark' ? 'light' : 'dark';
                applyTheme(newTheme);
                localStorage.setItem('theme', newTheme);
            });
            const savedTheme = localStorage.getItem('theme') || 'light'; // Default to light
            applyTheme(savedTheme);
        }

        // --- Font Size Control ---
        function applyFontSize(size) {
            contentElement.style.fontSize = size + 'px';
        }
        function initFontSizeControls() {
            const fontDecreaseBtn = document.getElementById('font-decrease');
            const fontIncreaseBtn = document.getElementById('font-increase');
            let currentFontSize = parseInt(localStorage.getItem('fontSize')) || DEFAULT_FONT_SIZE;
            applyFontSize(currentFontSize);

            fontIncreaseBtn.addEventListener('click', () => {
                if (currentFontSize < MAX_FONT_SIZE) {
                    currentFontSize += FONT_SIZE_STEP;
                    applyFontSize(currentFontSize);
                    localStorage.setItem('fontSize', currentFontSize);
                }
            });
            fontDecreaseBtn.addEventListener('click', () => {
                if (currentFontSize > MIN_FONT_SIZE) {
                    currentFontSize -= FONT_SIZE_STEP;
                    applyFontSize(currentFontSize);
                    localStorage.setItem('fontSize', currentFontSize);
                }
            });
        }

        // --- Expand/Collapse Act Sections in Main Content ---
        function initExpandCollapse() {
            contentElement.querySelectorAll('.toggle-sections-btn').forEach(button => {
                const sectionsWrapperId = button.getAttribute('aria-controls');
                const sectionsWrapper = document.getElementById(sectionsWrapperId);
                if (!sectionsWrapper) {
                    console.warn('Sections wrapper not found for button:', button);
                    return;
                }

                button.addEventListener('click', () => {
                    const isExpanded = button.getAttribute('aria-expanded') === 'true';
                    sectionsWrapper.querySelectorAll('.section').forEach(s => {
                        s.classList.toggle('collapsed-section', isExpanded);
                    });
                    button.setAttribute('aria-expanded', !isExpanded);
                    button.textContent = !isExpanded ? 'Collapse Sections' : 'Expand Sections';
                });
            });
        }

        // --- Table of Contents & Scroll Spy ---
        let tocLinks = [];
        let contentHeadings = []; // Store actual H2/H3 elements from content
        const SCROLL_SPY_OFFSET = 180; // Adjust based on your sticky header's height + some buffer

        function buildTOCAndPrepScrollSpy() {
            const tocList = document.getElementById('toc-list');
            tocList.innerHTML = ''; // Clear existing TOC items
            tocLinks = []; // Clear existing links
            contentHeadings = []; // Clear existing headings

            contentElement.querySelectorAll('.act-section').forEach(actDiv => {
                const actTitleElement = actDiv.querySelector('h2');
                if (!actTitleElement) return;

                const actId = actDiv.id || generateId(actTitleElement.textContent, "act");
                actTitleElement.id = actId; // Ensure the H2 has an ID
                contentHeadings.push(actTitleElement);

                const actLi = document.createElement('li');
                const actA = document.createElement('a');
                actA.href = '#' + actId;
                actA.className = 'toc-act-title';

                const toggleIcon = document.createElement('span');
                toggleIcon.className = 'toc-act-toggle-icon';
                toggleIcon.innerHTML = '&#9662;'; // Down arrow (expanded by default)
                actA.appendChild(toggleIcon);
                actA.appendChild(document.createTextNode(" " + actTitleElement.textContent));

                const sectionsUl = document.createElement('ul');
                sectionsUl.className = 'toc-sections'; // Initially expanded

                actA.addEventListener('click', (e) => {
                    const isIconClick = e.target === toggleIcon || e.target.parentElement === toggleIcon;

                    if (sectionsUl.hasChildNodes() && (isIconClick || e.target === actA)) { // Toggle if icon or title (with sections) clicked
                         e.preventDefault(); // Prevent default jump only if we are toggling
                        sectionsUl.classList.toggle('collapsed');
                        toggleIcon.classList.toggle('collapsed'); // For rotating the icon via CSS
                        toggleIcon.innerHTML = sectionsUl.classList.contains('collapsed') ? '&#9656;' : '&#9662;';
                    }
                     // Allow navigation if the click was on the text part of the link, not just the icon.
                     // The handleTOCClick will handle the smooth scroll.
                    if (!isIconClick) {
                         handleTOCClick(e, actA.getAttribute('href'));
                    }
                });
                actLi.appendChild(actA);
                tocLinks.push(actA); // Add Act title link to tocLinks for scrollspy

                actDiv.querySelectorAll('h3').forEach(h3 => {
                    const sectionId = h3.id || generateId(h3.textContent, actDiv.id + "-sec");
                    h3.id = sectionId; // Ensure H3 has an ID
                    contentHeadings.push(h3);

                    const sectionLi = document.createElement('li');
                    const sectionA_h3 = document.createElement('a');
                    sectionA_h3.href = '#' + sectionId;
                    sectionA_h3.textContent = h3.textContent;
                    sectionA_h3.onclick = (event) => handleTOCClick(event, sectionA_h3.getAttribute('href'));
                    sectionLi.appendChild(sectionA_h3);
                    sectionsUl.appendChild(sectionLi);
                    tocLinks.push(sectionA_h3);
                });

                if (sectionsUl.hasChildNodes()) {
                    actLi.appendChild(sectionsUl);
                }
                tocList.appendChild(actLi);
            });
        }

        function handleTOCClick(event, targetHref) {
            event.preventDefault(); // Prevent default jump to handle smooth scroll and history
            const targetElement = document.querySelector(targetHref);
            if (targetElement) {
                targetElement.scrollIntoView({ behavior: 'smooth', block: 'start' });
                if (history.pushState) {
                    history.pushState(null, null, targetHref);
                } else {
                    location.hash = targetHref;
                }
                if (window.innerWidth <= 900 && !tocSidebar.classList.contains('collapsed')) {
                    toggleTOC();
                }
            }
        }

        function toggleTOC() {
            tocSidebar.classList.toggle('collapsed');
            body.classList.toggle('toc-collapsed');
            body.classList.toggle('toc-open');
            tocToggleButton.innerHTML = tocSidebar.classList.contains('collapsed') ? '&#9776;' : '&times;';
        }

        function updateScrollSpy() {
            let currentSectionId = null;
            const scrollPosition = window.scrollY + SCROLL_SPY_OFFSET;

            // Iterate from bottom to top to find the last element above the scroll position
            for (let i = contentHeadings.length - 1; i >= 0; i--) {
                const heading = contentHeadings[i];
                const actSectionDiv = heading.closest('.act-section');
                const sectionsWrapper = actSectionDiv ? actSectionDiv.querySelector('[id$="-sections-wrapper"]') : null;
                const actToggleBtn = actSectionDiv ? actSectionDiv.querySelector('.toggle-sections-btn') : null;

                let isContentActVisible = true; // Is the Act's main content area expanded?
                if (actToggleBtn && actToggleBtn.getAttribute('aria-expanded') === 'false') {
                    isContentActVisible = false;
                }

                // Only consider if the heading is visible in the main content
                if (isContentActVisible && heading.offsetTop <= scrollPosition) {
                    currentSectionId = heading.id;
                    break;
                }
            }

            tocLinks.forEach(link => {
                link.classList.remove('active-toc-link');
                const href = link.getAttribute('href');
                if (href === '#' + currentSectionId) {
                    link.classList.add('active-toc-link');

                    // Ensure the active link and its parent Act TOC are visible
                    const tocSidebarEl = document.getElementById('toc-sidebar');
                    const parentActLi = link.closest('ul.toc-sections')?.closest('li'); // Find parent act li if this is a section link
                    
                    if (parentActLi) {
                        const parentActSublist = parentActLi.querySelector('ul.toc-sections');
                        const parentActToggleIcon = parentActLi.querySelector('.toc-act-toggle-icon');
                        if (parentActSublist && parentActSublist.classList.contains('collapsed')) {
                            parentActSublist.classList.remove('collapsed');
                            if(parentActToggleIcon) {
                                parentActToggleIcon.classList.remove('collapsed');
                                parentActToggleIcon.innerHTML = '&#9662;';
                            }
                        }
                    }
                    
                    // Scroll TOC to keep active link visible
                    if (link.offsetTop < tocSidebarEl.scrollTop || 
                        link.offsetTop + link.offsetHeight > tocSidebarEl.scrollTop + tocSidebarEl.clientHeight) {
                        tocSidebarEl.scrollTop = link.offsetTop - (tocSidebarEl.clientHeight / 3) + (link.offsetHeight / 2);
                    }
                }
            });
        }
        let scrollTimeout;
        window.addEventListener('scroll', () => {
            if (scrollTimeout) clearTimeout(scrollTimeout);
            scrollTimeout = setTimeout(updateScrollSpy, 100); // Slightly increased debounce
        });

        // --- Search Filter Population ---
        function populateSearchFilter() {
            const filterSelect = document.getElementById('search-act-filter');
            while (filterSelect.options.length > 1) { filterSelect.remove(1); } // Clear old options
            contentElement.querySelectorAll('.act-section').forEach(actDiv => {
                const actTitleElement = actDiv.querySelector('h2');
                if (actTitleElement) {
                    const actId = actDiv.id || generateId(actTitleElement.textContent, "act-filter");
                    actDiv.id = actId; // Ensure actDiv itself has an ID for search scoping
                    const option = document.createElement('option');
                    option.value = actId;
                    option.textContent = actTitleElement.textContent;
                    filterSelect.appendChild(option);
                }
            });
        }

        // --- Search Functionality (Modified for Filtering) ---
        function performSearch() {
            const contentToSearchInGlobal = document.getElementById('content');
            if (!originalContentHTML) { originalContentHTML = contentToSearchInGlobal.innerHTML; }
            else { contentToSearchInGlobal.innerHTML = originalContentHTML; }
            addCopyButtons(); // Re-add as they are part of originalContentHTML

            const searchTerm = document.getElementById('search-box').value;
            const filterValue = document.getElementById('search-act-filter').value;

            if (!searchTerm.trim()) {
                clearSearch(true); updateSearchStatus(); return;
            }

            const searchRegExp = new RegExp(escapeRegExp(searchTerm), 'gi');
            matches = [];

            let searchScopeElement;
            if (filterValue !== 'all') {
                searchScopeElement = document.getElementById(filterValue);
            } else {
                searchScopeElement = contentToSearchInGlobal; // Search all content
            }

            if (!searchScopeElement) { // Fallback if specific scope not found
                console.warn("Search scope element not found for filter:", filterValue, "Defaulting to all content.");
                searchScopeElement = contentToSearchInGlobal;
            }
            
            // Make sure all sections are expanded within the search scope for highlighting
            const tempExpandButtons = searchScopeElement.querySelectorAll('.toggle-sections-btn');
            const initiallyCollapsedWrappers = [];

            tempExpandButtons.forEach(btn => {
                const wrapperId = btn.getAttribute('aria-controls');
                const wrapper = document.getElementById(wrapperId);
                if (wrapper && btn.getAttribute('aria-expanded') === 'false') {
                    initiallyCollapsedWrappers.push(wrapperId); // Store ID
                    // Temporarily expand for search by simulating click or direct manipulation
                    wrapper.querySelectorAll('.section').forEach(s => s.classList.remove('collapsed-section'));
                    btn.setAttribute('aria-expanded', 'true');
                    btn.textContent = 'Collapse Sections';
                }
            });


            function highlightInNode(node) { // Only highlight within the searchScopeElement
                if (!searchScopeElement.contains(node) && node !== searchScopeElement) {
                     // If node is not within scope (and not scope itself), but has children, recurse if those children might be in scope.
                     // This is complex. A simpler way is to only start recursion from searchScopeElement.
                     // For now, this direct check should mostly work if highlightInNode starts from contentToSearchInGlobal.
                    return; 
                }

                if (node.nodeType === Node.TEXT_NODE) {
                    const text = node.nodeValue; let match; const fragment = document.createDocumentFragment(); let lastIndex = 0;
                    while ((match = searchRegExp.exec(text)) !== null) {
                        if (match.index > lastIndex) { fragment.appendChild(document.createTextNode(text.substring(lastIndex, match.index))); }
                        const span = document.createElement('span'); span.className = 'highlight'; span.appendChild(document.createTextNode(match[0])); fragment.appendChild(span); matches.push(span); lastIndex = searchRegExp.lastIndex;
                    }
                    if (lastIndex < text.length) { fragment.appendChild(document.createTextNode(text.substring(lastIndex))); }
                    if (fragment.childNodes.length > 0) { node.parentNode.replaceChild(fragment, node); }
                } else if (node.nodeType === Node.ELEMENT_NODE && node.childNodes &&
                           !/^(script|style|button|input|textarea|select)$/i.test(node.tagName) &&
                           !node.closest('#top-controls-wrapper') && !node.closest('#toc-sidebar')) {
                    Array.from(node.childNodes).forEach(child => highlightInNode(child));
                }
            }
            
            // IMPORTANT: Always highlight on the *full original document structure* that might be restored later
            // but ensure matches are only pushed if they are within the current searchScopeElement.
            // The actual highlighting will happen on the full DOM.
            // The `matches` array will be filtered after.
            
            const tempFullMatches = []; // Store all highlights first

            function findAndHighlight(node) {
                 if (node.nodeType === Node.TEXT_NODE) {
                    const text = node.nodeValue; let match; const fragment = document.createDocumentFragment(); let lastIndex = 0;
                    while ((match = searchRegExp.exec(text)) !== null) {
                        if (match.index > lastIndex) { fragment.appendChild(document.createTextNode(text.substring(lastIndex, match.index))); }
                        const span = document.createElement('span'); span.className = 'highlight'; span.appendChild(document.createTextNode(match[0])); fragment.appendChild(span); 
                        if (searchScopeElement.contains(node)) { // Only add to actual matches if in scope
                            matches.push(span); 
                        }
                        lastIndex = searchRegExp.lastIndex;
                    }
                    if (lastIndex < text.length) { fragment.appendChild(document.createTextNode(text.substring(lastIndex))); }
                    if (fragment.childNodes.length > 0) { node.parentNode.replaceChild(fragment, node); }
                } else if (node.nodeType === Node.ELEMENT_NODE && node.childNodes && !/^(script|style|button|input|textarea|select)$/i.test(node.tagName) && !node.closest('#top-controls-wrapper') && !node.closest('#toc-sidebar')) {
                    Array.from(node.childNodes).forEach(findAndHighlight);
                }
            }
            findAndHighlight(contentToSearchInGlobal); // Perform highlighting globally

            // Restore originally collapsed sections if they were outside the immediate search scope or if filter is "all"
            // This is to ensure UI consistency post-search.
            if (filterValue === "all") { // If searching all, restore all initially collapsed sections
                 initiallyCollapsedWrappers.forEach(wrapperId => {
                    const wrapper = document.getElementById(wrapperId);
                    const btn = wrapper.closest('.act-section').querySelector('.toggle-sections-btn');
                    wrapper.querySelectorAll('.section').forEach(s => s.classList.add('collapsed-section'));
                    btn.setAttribute('aria-expanded', 'false');
                    btn.textContent = 'Expand Sections';
                });
            } else { // If filtering, only restore those *not* in the current searchScopeElement
                document.querySelectorAll('.act-section .toggle-sections-btn').forEach(btn => {
                    const wrapperId = btn.getAttribute('aria-controls');
                    if (initiallyCollapsedWrappers.includes(wrapperId) && !searchScopeElement.querySelector(`#${wrapperId}`)) {
                        const wrapper = document.getElementById(wrapperId);
                        wrapper.querySelectorAll('.section').forEach(s => s.classList.add('collapsed-section'));
                        btn.setAttribute('aria-expanded', 'false');
                        btn.textContent = 'Expand Sections';
                    }
                });
            }


            currentMatchIndex = -1;
            if (matches.length > 0) { currentMatchIndex = 0; goToMatch(currentMatchIndex); }
            updateSearchStatus();
        }

        function updateSearchStatus() {
            const statusSpan = document.getElementById('search-status'); const prevBtn = document.getElementById('prev-match'); const nextBtn = document.getElementById('next-match');
            if (matches.length === 0) { statusSpan.textContent = document.getElementById('search-box').value.trim() ? '0 found' : ''; prevBtn.disabled = true; nextBtn.disabled = true; }
            else { statusSpan.textContent = `${currentMatchIndex + 1} of ${matches.length}`; prevBtn.disabled = currentMatchIndex <= 0; nextBtn.disabled = currentMatchIndex >= matches.length - 1; }
        }
        function goToMatch(index) {
            if (index < 0 || index >= matches.length) return;
            if (currentMatchIndex !== -1 && matches[currentMatchIndex]) { matches[currentMatchIndex].classList.remove('current-match'); }
            currentMatchIndex = index; const currentElement = matches[currentMatchIndex];
            if (!currentElement) return; // Safety check
            currentElement.classList.add('current-match');
            currentElement.scrollIntoView({ behavior: 'smooth', block: 'center' }); updateSearchStatus();
        }
        function goToNextMatch() { if (currentMatchIndex < matches.length - 1) { goToMatch(currentMatchIndex + 1); } }
        function goToPreviousMatch() { if (currentMatchIndex > 0) { goToMatch(currentMatchIndex - 1); } }

        function clearSearch(keepSearchTerm = false) {
            const contentDiv = document.getElementById('content');
            if (originalContentHTML) { contentDiv.innerHTML = originalContentHTML; addCopyButtons(); initExpandCollapse(); /* Re-init expand/collapse state and listeners */ }
            matches = []; currentMatchIndex = -1;
            if (!keepSearchTerm) { document.getElementById('search-box').value = ''; }
            // Reset expand/collapse buttons to their default "Collapse Sections" text
            document.querySelectorAll('.toggle-sections-btn').forEach(button => {
                button.textContent = 'Collapse Sections';
                button.setAttribute('aria-expanded', 'true');
            });
            updateSearchStatus();
        }

        const scrollToTopButton = document.getElementById('scroll-to-top');
        function handleScroll() { if (window.scrollY > 300) scrollToTopButton.classList.add('show'); else scrollToTopButton.classList.remove('show'); }
        function scrollToTopFunc() { window.scrollTo({ top: 0, behavior: 'smooth' }); }

        document.addEventListener('DOMContentLoaded', () => {
            originalContentHTML = contentElement.innerHTML; // Store initial content structure
            
            initThemeToggle();
            initFontSizeControls();
            buildTOCAndPrepScrollSpy(); // Must be after content is available but before expand/collapse if it relies on section visibility
            initExpandCollapse(); // Initialize expand/collapse listeners
            populateSearchFilter();
            addCopyButtons();

            tocToggleButton.addEventListener('click', toggleTOC);
            scrollToTopButton.addEventListener('click', scrollToTopFunc);
            window.addEventListener('scroll', handleScroll); // For scroll-to-top button, scroll spy handled separately

            document.getElementById('search-box').addEventListener('keypress', (e) => { if (e.key === 'Enter') { e.preventDefault(); performSearch(); } });
            document.getElementById('search-act-filter').addEventListener('change', performSearch); // Re-search on filter change


            window.addEventListener('resize', () => {
                 if (window.innerWidth > 900) { body.classList.remove('toc-collapsed', 'toc-open'); tocSidebar.classList.remove('collapsed'); tocToggleButton.innerHTML = '&times;'; }
                 else { if (!tocSidebar.classList.contains('collapsed')) { body.classList.add('toc-open'); body.classList.remove('toc-collapsed'); tocToggleButton.innerHTML = '&times;'; }
                 else { body.classList.add('toc-collapsed'); body.classList.remove('toc-open'); tocToggleButton.innerHTML = '&#9776;'; } }
            });
            if (window.innerWidth <= 900) { body.classList.add('toc-collapsed'); tocSidebar.classList.add('collapsed'); tocToggleButton.innerHTML = '&#9776;'; }
            else { tocToggleButton.innerHTML = '&times;'; }
            
            updateScrollSpy(); // Initial call for scroll spy
        });

        async function copySectionText(buttonElement) {
            const sectionDiv = buttonElement.closest('.section');
            if (sectionDiv) {
                const tempDiv = sectionDiv.cloneNode(true);
                const buttonInClone = tempDiv.querySelector('.copy-button');
                if (buttonInClone) buttonInClone.remove();
                const textToCopy = tempDiv.innerText.trim();
                try {
                    await navigator.clipboard.writeText(textToCopy);
                } catch (err) {
                    const textArea = document.createElement("textarea");
                    textArea.value = textToCopy; document.body.appendChild(textArea);
                    textArea.focus(); textArea.select();
                    try { document.execCommand('copy'); } catch (execErr) { console.error('Fallback copy failed: ', execErr); alert('Failed to copy text.'); return; }
                    document.body.removeChild(textArea);
                }
                const originalText = buttonElement.textContent;
                buttonElement.textContent = 'Copied!';
                setTimeout(() => { buttonElement.textContent = originalText; }, 1500);
            }
        }
        function addCopyButtons() {
            document.querySelectorAll('.act-section .section h3').forEach(h3 => {
                let copyBtn = h3.parentNode.querySelector('.copy-button');
                if (!copyBtn) {
                    const button = document.createElement('button');
                    button.textContent = 'Copy'; button.className = 'copy-button'; button.title = 'Copy section text';
                    button.onclick = (e) => copySectionText(e.target);
                    h3.parentNode.insertBefore(button, h3); // Insert before H3
                }
            });
        }
    </script>
</body>
</html>
